Epidemiology of Hepatitis A in Al Ain: With Emphasis on Age-Related Seroprevalence by Al Shamisi, Salwa Saeed
United Arab Emirates University
Scholarworks@UAEU
Theses Electronic Theses and Dissertations
2007
Epidemiology of Hepatitis A in Al Ain: With
Emphasis on Age-Related Seroprevalence
Salwa Saeed Al Shamisi
Follow this and additional works at: https://scholarworks.uaeu.ac.ae/all_theses
Part of the Environmental Sciences Commons
This Thesis is brought to you for free and open access by the Electronic Theses and Dissertations at Scholarworks@UAEU. It has been accepted for
inclusion in Theses by an authorized administrator of Scholarworks@UAEU. For more information, please contact fadl.musa@uaeu.ac.ae.
Recommended Citation
Al Shamisi, Salwa Saeed, "Epidemiology of Hepatitis A in Al Ain: With Emphasis on Age-Related Seroprevalence" (2007). Theses. 516.
https://scholarworks.uaeu.ac.ae/all_theses/516
United Arab E mirates U niversity 
Deanship of Graduate Studies 
M. Sc. Progra m in Enviro n mental Science 
Epidemiology of Hepatitis A in Al Ain: 
with Emphasis on Age-related 
Seroprevalence 
By 
Salwa Saeed AI S h a m isi  
A thesis submitted to United Arab E m irates University in  
partial fulfillment of the requirements for the 
degree of M. Sc. i n  E nviron mental Science 
2006-2007 
United Arab E m irates University 
Deanship of Graduate Studies 
M. Sc. Program i n  E nviro n mental Science 
Epidemiology of Hepatitis A in AI Ain: 
with Emphasis on Age-related 
Seroprevalence 
By 
Salwa Saeed AI Shamisi  
Principal Supervisor: 
Dr. Youssef Ali Abu-Zeid 
Department of Biology 
College of Science 





Prof. Miodrag Lukic 
Dept. Of Medical Microbiology 
College of Medicine and Health 
Sciences 
United Arab E mirates 
University 
The Thesis of Salwa Saeed Ai Shamisi for the Degree of Master of 
Science in Environmental is approved . 
.. .. .. .. .. .. .. .. .. .. .. .. .. .. � .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. ..  .. 
Examining Committee Member, Dr. Youssef Ali Abu Zeid . 
.. .. .. .. .. .. .. .. .. .. .. .... .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. .. ... . .. .... .. .. .. .. .. .. . . .. .. .. .. .. . . ... .. .. .. .  ... .. . . .. .... .. .. . . ..  .. 
Examining Committee Member, Dr. Roos Bernsen. 
Examining Committee Member, Dr. Tareq Youssef. 
. ....... . . ... . . . . . ; 
I 
Dean of the Graduate Studies, Professor James E. P'tt'�� 
United Arab Emirates University 
2006/2007 
DEDICATION 




I wish to express my deepest appreciation to my major supervisor Dr. Youssef 
Abu-Zeid for his continuous supervision, endless support, and patience. He bas been so 
generous in supplying me the necessary advice to complete this work. Also, I would like to 
thank my second supervisor Prof. Miodrag Lukic for his encouragement and professional 
experience, helping in providing the facilities especially the working area in Tawam 
hospital. Moreover, I am greatly thankful to my other supervisor who passed away last 
year because of cureless disease Dr. Rafie Alwash, the previous Director of Preventive 
Medicine in Al Ain Medical District, for his professional and scientific experience. 
I wish to present my thanks to Mr. Hamad Al Mulla (Director of Blood Banks, 
Chief Medical Technologist of Clinical Laboratory in Tawam Hospital) and Miss. Samar 
Abdel Khalik (Chief Department of Serology, Clinical Laboratory, Tawam hospital) for 
their effort in helping me during samples collection and analysis stages of this study. Many 
thanks also go to all members of the Research Committee in Tawam Hospital who gave 
me the permission and access to the working area which was the clinical laboratory within 
the hospital. In addition I would like to thank all the staff of the clinical laboratory 
especially phlebotomy department in Tawam Hospital. Many thanks go to the primary 
health care clinics in Al All, namely Ood Al Toba and Al Khabisi clinics. 
Many thanks for statistical consultation are due to Dr. Taoufik A. Zoubeidi, 
statistics track, College of Business and Economics, UAB University. 
This work was accomplished mainly with the support and grant of the 
Environmental Science Program Graduate studies in the UAB University which are 
gratefully acknowledged. 
lV 
I am greatly thankful to all the people who participated in my study, without their 
cooperation, this work would not be in the limelight. 
I would like to acknowledge my family and Dr. Waleed Barnza for their spiritual 
support they have been of great help and support to me. Finally, thanks are also extended 
to the soul of Dr. Bazzem Abdul Rahman who was very supportive and interested in my 
work. 
SAL WA S. AL SHAMISI. 
v 
ABSTRACT 
Hepatitis A (HAY) is common worldwide, but with falling sero-prevalence in residents of 
de eloped countries is an indication of improved food and water hygiene. It is well known that the 
sero-prevalence of hepatitis A are highly correlated with socioeconomic status. The main objective 
of this study was to have base line data on the age-related sero-prevalence of HAY in Al All 
district and the possible risk factors. 
Blood and a questionnaire data were obtained from 280 UAE citizens' outpatients of Tawam 
Hospital and 333 expatriates' inhabitants of AI Ain city. The expatriate subjects were 
heterogeneous coming from 24 different countries. UAE nationals in general have different social 
habits, higher income and better standard of living compared to expatriates. This study investigates 
mainly the effects of improvement in the living standard particularly hygiene and sanitation in Al 
Ain city as a symbol for UAE in general on the prevalence of hepatitis A. The age range of subjects 
was 0 to 39 years old. A micro-particle enzyme immunoassay (MElA), "AxSYM system 
HAY AB® 2.0", was used for the detection of total antibodies for hepatitis A virus (HA V). 
This study provides the first evidence that AI Ain should be considered as an area of 
intermediate endemicity. Furthermore, it points out to the need of considering the ethnic 
composition in perspective when analyzing the epidemiological data on hepatitis A, as differential 
exposure to the virus was evident in UAE nationals and expatriates. Using logistic regression; age, 
gender, subject education and occupation of the UAE nationals were found as possible risk factors. 
Age, subject education, occupation and history of international travel were found as possible risk 
factors within the expatriates. However, using multivariate logistic regression, age turned out to be 
the only significant independent risk factor for the UAE nationals, while occupation for the 
expatriates. The significance of the results is discussed in the light of the known world wide and 
regional prevalence and risk factors ofHA V. The results of the present study considered as the first 
seroprevalence study to cover a wide range of age groups within both UAE nationals and 
VI 
e patriates in Al Ain strongl pointed to the need for more epidemiological studies, preferably 
nationwide, in order to assess the current and future of hepatitis A in UAE and the possible need to 
accinate susceptible groups in the population to avoid any possible hepatitis A out-break. 
Vll 
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I. INTRODUCTION 
1.1. The Liver 
1.1.1. Embryology 
I. INTRODUCTION 
The embryological origins of the liver, bile ducts and pancreas are strongly related 
to each other. In addition, the vascular and biliary connections between the liver and the 
other organs of the gastrointestinal tract are important for its normal functioning. 
Therefore, any embryological abnormalities of these systems can cause potentially life­
threatening conditions. Similarly the symbiotic relationship between these organs means 
that disease processes affecting one will mostly affect the other (Aspinall and Taylor­
Robinson, 2002). 
1 . 1 .2 .  Anatomy 
The liver is considered as the largest gland in the body. The liver occupies the 
greater part of the right upper abdominal cavity, and extends from the right lateral aspect of 
the abdomen 15 to 20 cm transversely towards the xiphoid. According to the overall body 
size the weight of the adult liver varies from 1200 to 1800 grams, and consumes 
approximately about 1.8% to 3.1 % of the total body weight (Kanel, 2003; Marieb, 2006). 
The normal liver weighs around 1500 g and consists of a continuous mass of cells 
incompletely separated by connective tissue septae. Within this continuous cell mass, the 
sub-divisions of the bile ducts and the hepatic vasculature create numerous connections 
(Reinus, 1999; Aspinall and Taylor-Robinson, 2002). In general, the liver is considered to 
be composed of lobes (Figure 1). A large right and a smaller left lobe are separated by the 
line of insertion of the falciform ligament (Bastian, 1994). The right lobe comprising of 
five sixths, while the left lobe, one sixth, from the total hepatic mass (Reinus, 1999). 
2 
The liver anatomically can be divided into fOUI lobes: right, left caudate, and quadrate. 
The right lobe accounts for one half to two thirds of the total liver volume; but, 
functionally the right and left lobes play an equal role. These lobes are divided by a line 
e tending from the inferior vena cava superiorly to the middle of the gallbladder fossa 
inferiorly. A total of eight functional segments are available, each demarcated by the 
vascular and biliary drainage (kanel, 2003; Marieb, 2006). 
The liver consists of a wide range of cell types. About 60% are hepatocytes; in 
addition, there are also significant numbers of biliary epithelial cells and 'non-parenchymal' 
cells including endothelium, Kupffer cells and Stellate cells (Aspinall and Taylor­
Robinson, 2002). Hepatocytes occupy about 80-88% of the total liver volume in humans 








Figure 1 :  Shows general liver structure, left and right lobe, hepatic duct (Bastian, 1994). 
1 . 1 .3. H istology 
A liver Lobule is considered as the basic structural and functional unit of the liver 
which consists of hepatic cells (specialized epithelial cells) arranged in irregular, 
branching, interconnected plates around a central vein as shown in figure 2 (Reinus, 1999). 
3 
These epithelial cells which are called hepatocytes perform large variety of 
functions including secretion of bile. Hepatocytes lie in plates which are separated by 
blood-filled sinusoids which are arranged radially around a central efferent hepatic vein 
with peripheral portal tract areas that contain distal branches of the hepatic artery, portal 
vein and bile duct (Bastian 1994; Aspinall and Taylor-Robinson, 2002). Every single 
hepatocyte is a polyhedral and highly polarized epithelial cell about 30-40 j.lm in diameter 
(O'Grady et al., 2000). Central vein passing through the center of a lobule; carries blood 
from the hepatic cells to a branch of the hepatic vein, which empties into the inferior vena 
cava (Reinus, 1999). Within the liver there are large spaces called sinusoids or sinusoidal 
capillaries lined by endothelium through which the blood passes. These sinusoidal 
capillaries have larger diameters than other capillaries, large intercellular clefts between 
the endothelial cells, an incomplete basement membrane, and an irregular shape. Branches 
of both the hepatic portal vein (nutrient-rich deoxygenated blood) and the hepatic artery 
(oxygenated blood) carry blood into the liver sinusoids (Reinus, 1999; O'Grady et al., 
2000). Then, there are the Stellate reticuloendothelial cells or Kupffer's cells which are 
phagocytic cells lining the sinusoids. The main functions of these cells are to destroy worn­
out blood cells, bacteria and toxic substances (Bastian, 1994). 
Arten,,-:>le $inUSDld 
Figure 2: Shows liver parenchyma. The hepatocytes are arranged in plates that converge 
on the central vein (Reinus, 1999). 
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The smallest portions of the bile duct system are the Bile Ducts Canaliculi (bile 
capillaries). A bile canaliculus is located between each closest pair of hepatocytes; the 
canalicular wall consists of a specialized part of the liver cell membrane covered by 
microvilli. Bile secreted by hepatocytes enters the canaliculi and empties into small ducts 
that combine to form the right and left hepatic ducts; left and right hepatic ducts come 
together and exit the liver as the common hepatic duct and joins the cystic duct from the 
gallbladder, to form the common bile duct. The latter and the pancreatic duct connect 
together to form a common duct which is called the hepatopancreatic ampulla, which 
empties into the duodenum (Bastian, 1994; Reinus, 1999). 
1. 1 .4. Physiology 
The liver is located under the diaphragm on the right side of the abdominal cavity. 
All nutrients which are absorbed by the small intestine (except complex lipids) are 
transferred to the liver by the hepatic portal system, where they are processed to be used by 
other body organs (Bastian, 1994). The complex physiology of the liver is one of the most 
important factors that causes delayed development of artificial liver support devices 
(Aspinall and Taylor-Robinson, 2002). It is useful to imagine the liver as a metabolically 
active filter. This filter is interposed between the splanchnic and circulation system. 
Splanchnic blood inflowing the liver carries nutrients and foreign antigens, while systemic 
blood leaving the liver should have a stable composition to be able to support the life and 
well being of all body tissues. As a result, one of the main functions of the liver is to 
regulate the composition of the blood (Reinus, 1999). The production of bile, which is 
released into the small intestine helps the breakdown of fats during digestion. The liver 
makes bile continuously, even when food is not being digested, and extra bile is stored in 
the gallbladder (Aspinall and Taylor-Robinson, 2002). Bile consists of two different 
5 
fraction . The first fraction is only produced when sufficient bile acids are available from 
the blood. This bile-acid dependent fraction is produced by the canalicular cells. While the 
production of the second fraction is independent of bile acid availability and is produced 
by the duct cell (Davies et al, 2001). 
Other important functions of the liver include: the production of certain proteins 
that circulate in the blood, such as albumin and several factors responsible for clotting, the 
production of cholesterol and special proteins (lipoproteins) that help carry fats through the 
body, the conversion of excess glucose (sugar) into a starch-like compound called 
glycogen and storage of this glycogen in the liver. Glycogen can later be converted back to 
glucose for energy whenever it is needed (O'Grady et al., 2000). 
In addition, the liver can regulate blood levels of amino acids, which form the 
building blocks of proteins. It also plays an important role in the storage of iron that is used 
in the processing of hemoglobin in the blood (hemoglobin is essential for carrying oxygen 
in the blood) as well as conversion of ammonia in the blood to urea. The bacteria of the 
intestinal tract produce ammonia as they break down proteins, and ammonia can 
accumulate in the blood at potentially toxic levels. U rea is a safer product than ammonia 
and is excreted in the urine. Resisting infections by producing immune factors and filtering 
bacteria from the blood stream is another function of the liver (O'Grady et aI., 2000; 
Aspinall and Taylo-Robinson, 2002). 
1 . 1 .5. Some l iver d iseases 
In many instances, liver diseases, biliary tract or pancreatic diseases can occur with 
similar patterns of symptoms to other digestive system organs such as abdominal pain, 
weight loss, diarrhea or bleeding. A liver disease is commonly an incidental finding, 
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discovered on 'routine' laboratory tests or on the screening of blood donations (Aspinall 
and Taylor-Robinson 2002). 
The commonest presentation of patients with liver and biliary disease is jaundice. 
Patients with high concentrations of bilirubin (> 1 00 Ilmol/l) or with indication of sepsis are 
at high risk of developing complications and should be referred as an emergency for any 
delays in treatment adversely affect diagnosis. Hyperbi lirubinaemia can be defmed as a 
bilirubin concentration above the normal laboratory upper limit which is about 18-19 
Ilmoill. Jaundice occurs when bilirubin becomes visible within the sclera, skin, and 
mucous membranes and a bilirubin blood concentration of approximately 40 IlmoVl. 
Jaundice can be categorized as pre-hepatic, hepatic, post-hepatic, and this provides a useful 
framework for identifying the underlying cause (Beckingham and Rayder, 2001; Aspinall 
and Taylo-Robinson, 2002). 
listed under are some examples of liver diseases: Fatty Infiltration, Cirrhosis, 
Hemochromatosis, Biliary Obstruction Proximal, Biliary Obstruction Distal, Common 
Duct Stricture, Passive Hepatic Congestion, Hepatocellular Carcinoma, Hepatic Trauma, 
Amebic Abscess, Hydatid disease, Acute Hepatitis, Chronic Hepatitis, Autoimmune 
Hepatitis and many other liver diseases (Colon and Snydman, 2000; Beckingham and 
Rayder, 2001; Aspinall and Taylor-Robinson, 2002). 
Because, the main disease which is covered in this synopsis is hepatitis A, a brief 
account of acute and chronic hepatitis i s  required. 
A Hepatotropic virus is considered as one of the main causes of mortality and 
morbidity which i nfects hundreds of millions of people worldwide. Beside their acute 
effects, infection with certain hepatitis viruses can cause long-term complications such as 
cirrhosis and primary liver cancer. Hepatic illnesses can also be caused by other viral 
pathogens such as Cytomegalovirus, Epstein-Barr virus, HIV, Measles and Herpes 
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imple virus. The patterns of illness caused by these agents vary widely and range from 
asymptomatic subclinical infection to fulminant hepatitis in association with acute liver 
failure (Aspinall and Taylo-Robinson, 2002). 
1.1.5.1. Vi ra l  Hepatitis 
A. Acute 
Acute Hepatitis is an inflammation of the liver. It is caused by one of several 
hepatotropic viruses known as Hepatitis A, B, C, D and E (Table 1). It is the most 
widespread liver disease in the world and most common cause of jaundice clinically, 
although only a third of patients with acute hepatitis A infections are jaundiced (Rayder 
and Beckingham, 2001). The typical clinical hepatitis A with jaundice only occurs after 
infection with HA V in about 10% of children under 6 years old, in 40-50% of older 
children and in 70-80% of adults. Therefore, at least half of the total numbers of infections 
are asymptomatic. Moreover not all clinical cases are confirmed by different serological 
tests (Cianciara, 2000). 
Hepatitis viruses can be classified into two main different groups: the enterically 
transmitted non-enveloped agent which include hepatitis A virus (HA V) and hepatitis E 
virus (HEV); and the blood-borne enveloped agents which include hepatitis B virus 
(HBV), hepatitis D virus (HDV), and hepatitis C virus (HCV). A fourth blood-borne agent, 
hepatitis G virus (HGV) , but pathogenicity of this virus remains unclear (Koff, 1999; 
Aspinall and Taylo-Robinson, 2002; Liang, 2003). 
In addition, acute viral hepatitis can be defmed as a primary infection of the liver 
by viruses that cause injury to hepatocytes and is characterized by a collection of clinical, 
biochemical, and pathological features. There are five hepatotropic viruses (A, B, C, D, 
and E) which account for more than 90% of hepatitis cases. The primary site of infection 
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and replication of hepatotropic viruses is the liver. Four viruses (HA V, HCV HDV, and 
HEV) are single-stranded RNA viruses while HBV is a partially double-stranded DNA 
viru (Liang, 2003). 
B. Chronic 
Chronic hepatitis exists when there is clinical or biochemical evidence of hepatic 
inflammation for at least three to six months. Hepatitis B or C virus can cause most cases 
of chronic viral hepatitis. Hepatitis B virus is considered as one of the commonest chronic 
viral infections in the world (Ryder and Beckingham, 2001; Gish and Garcia-Kennedy, 
2003). About 170 million people are chronically infected with hepatitis B worldwide. In 
developed countries such as United Kingdom and United States it is relatively uncommon 
with a prevalence of 182 per 100000 population. In areas of high endemicity, the main way 
of spread is vertical transmission from carrier mother to child, and this may account for 40-
50% of all hepatitis B infections in highly endemic areas. Because of more than 95% of 
children born to infected mothers, become infected, and develop chronic viral infection. 
Vertical transmission is considered as higbly efficient means of transmission. On the other 
hand, in low endemicity countries, the virus is mainly spread by either sexual or blood 
contact among people at high risk such as: intravenous drug users, patients receiving 
haemodialysis, and homosexual men. Men are more likely to develop chronic infection 
than women, although the reasons for this are unknown (Rayder and Beckingham, 2001). 
Around 300 million people have chronic hepatitis C infection worldwide. In 
contrast to hepatitis B virus, hepatitis C infection is not exclusive to the developing world, 
for example 0.3% to 0.7% of the United Kingdom population is infected. The virus is 
spread almost by blood contact. In Northern Europe, about 15% of infected patients have a 
history of blood transfusion and about 70% have used intravenous drugs. Sexual 
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transmission can be one of the causes, but it is unusual as less than 5% of long term sexual 
partners become infected. Vertical transmission of hepatitis C is unusual (Rayder and 
Beckingham, 2001). 
Table 1: Shows a general comparison between the six types of hepatitis viruses (Brooke et 
al., 2001). 
Virus Hepatitis A Hepatitis E Hepatitis B Hepatitis C Hepatitis D Hepatitis G 
fam ily Picomaviridae caliciviridae Hepadnaviridae Flaviviridae Unclassified Flaviviridae 
;enus Hepatovirus Unnamed Orthohepadnavirus Hepacivirus Deltavirus Unnamed 
lirion 27-28 nm, 3 0-32 nm, 60 nm, 35 nm, 60 nm, 
42 run, spherical 
icosahedral icosahedral spherical spherical spherical 
�nvelope Yes 
No No Yes (HBsAg) Yes Yes 
(HBsAg) 
;enome ssRNA ssRNA dsDNA ssRNA ssRNA ssRNA 
;enome size 7 .5  kb 7 .6  kb 3 .2 kb 9.4 kb 1.7 kb 9.4 kb 
itability Heat- and Ether-sensitive, Acid- Ether-
Heat-stab le Acid-sensitive 
ac id-stable Acid-sensitive sensitive sensitive 
lransmission Fecal-oral Fecal-oral Parenteral Parenteral Parenteral Parenteral 
>revalence Low, 
High Regional H igh Moderate Moderate 
regional 
{ulminant  
Rare In pregnancy Rare Rare Frequent ? 
lisease 
::hronic 
Never Never Often Often Often ? 
lisease 




There are still some unexplained cases of presumed viral hepatitis for which the 
infective agents have yet to be discovered. The presumed viral cases of acute liver failure 
for which unknown virus is found the term "hepatitis F" has been used to represent it. 
Recently, an RNA virus has been identified and labeled as hepatitis G (HGV) which can 
be a cause of some parenterally transmitted non A-E hepatitis. The virus is a member of 
the flavivirus with an approximately 30% homology to hepatitis C virus (Aspinall and 
Taylo-Robinson,2002). 
1.2. Hepatitis A virus 
1.2.1. History 
The literature of ancient Chinese made reference to the occurrence of jaundice. But, 
it was not before the 17th, 18th, and 19th centuries that scattered outbreaks of jaundice 
affecting diverse populations were more frequently reported. The disease was called 
campaign jaundice because it was more common among the military. In 1912 Cockayne 
made an accurate accounting of epidemic jaundice. Cockayne believed that the disease 
reached the liver through the blood, although the aerosol route was wrongly considered to 
be the principal mode of infection spreading. Cockayne described the epidemic form of the 
disease as term infectious hepatitis. The pattern of illness was summarized by a scientist 
called Blumer in 1923 from data of 63 outbreaks of epidemic jaundice reported in the 
United States between 1812 and 1922. Most infections affected children or young adults 
which developed 7 to 10 days after exposure to a patient with jaundice, showed a peak 
incidence especially in the fall and winter seasons, and had a tendency to be transmitted by 
person-to-person contact. These early observations established the presence of one of the 
major type of viral hepatitis, which is now known as viral hepatitis type A. Epidemiologic 
studies and human volunteer experiments which were done during and after World War II 
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helped in confirming the viral etiology of hepatitis A disease and its uniqueness from 
homologous serum jaundice and another form of hepatitis having a longer incubation 
period (Hollinger and Emerson, 2001). Serum hepatitis can spread through injections, 
mainly by blood transfusion. While the infectious hepatitis is acquired by the oral route 
and can be labeled as 'infectious' or 'catarrhal' hepatitis. Serum hepatitis had a long 
incubation period of 2-5 months, while the infectious hepatitis had shorter period, about 2-
6 weeks (Collier and Oxford, 1993). 
McCollum was the first who introduced the terms hepatitis A and hepatitis B to 
classify these diseases in 1947. These terms have been implemented by the World Health 
Organization (WHO) Committees on Viral Hepatitis to replace the many old descriptions 
previously applied (Hollinger and Emerson, 2001). 
The virus was clearly identified for the first time by immune electron microscopy 
in the feces sample as reported by Feinstone in 1973 (Hollinger and Emerson, 2001). In 
1975 highly sensitive immunoassays were then developed for detecting the HA V antigen 
and antibody culminating in the development of immunoglobulin M (IgM)-specific anti­
HA V tests to differentiate between the recent HA V infections from a previous one 
(O'Grady et al" 2000; Hollinger and Emerson, 2001). The major step which contributed to 
the development of a vaccine was in 1979, when Provost and Hilleman were successful in 
cultivating and serially passing on HA V in cell culture (Hollinger and Emerson, 2001). 
1.2.2. Morphology and Properties 
Hepatitis A, the most common defmed cause of viral hepatitis worldwide, is a 
member of the picomaviridae family and is an icosahedral particle about 27-28 DID in 
diameter as in figure 3. The hepatitis A virus genome is single stranded, linear, positive 
sense and contains about 7.5 kb RNA. Hepatitis A virus can be considered as spherical 
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with cubic symmetry irus that is a member of the Genus Hepatovirus in the Family 
Picomaviridae (Bannister et al. , 1996; Brooks et aI., 2001; Cuthbert, 2001; Bum, 2002). 
Previously hepatitis A classified as enterovirus 72, has now been assigned its own Genus 
which is Hepatovirus (Bums, 2002). Hepatitis A virus replicates in the cytoplasm of 
infected hepatocytes and gastrointestinal epithelial cells (Koff, 1999; Brundage and 
Fitzpatrick, 2006). 
The hepatitis A virus does not have an envelope but has a capsid comprising of 32 
subunits, each of which containing four major polypeptides named VP I to VP4. Although 
there is only one serotype of the hepatitis A virus, (Collier and Oxford, 1993; Brooks et aI., 
2001; Burn, 2002; Sanchez et al. 2003) four HA V genotypes have been identified in 
human infection. In addition, all the human strains are very closely related antigenically, 
and infection with one strain can cause immunity to the other strains (O'Grady et aI., 
2000). 
Figure 3: Electron microscopy picture of human hepatitis A virus (From: Centers for 
Disease Control and Prevention (CDC), Atlanta, USA). 
13 
1 .2.3. T ran mi ion 
Hepatitis A virus (HA V) is transmitted mainly by the fecal-oral route and it is 
common worldwide. The mode of acquisition is by direct person-to-person contact through 
the fecal-oral route or by ingestion of contaminated food or water. It may be associated 
with outbreaks, often from a common food source (Conlon and Snydman, 2000; Kalaajieh 
et aI. 2000; O'Grady et al., 2000; Bonanni et al, 2001; Marshall, 2004; Mims et al., 2004). 
For example, eating shellfish has been considered as one of the major risk factors for 
hepatitis A infection, particularly when these products are eaten raw or slightly cooked. 
Additionally, cooking does not always provide assurance of the harmlessness of shellfish. 
HA V is known to be inactivated by heat. Heat can cause coagulation and breakdown of the 
virus protein coat of the virus, but the surrounding environment, in which viruses are 
found possibly can influence their sensitivity to thermal inactivation (Ciccozzi, 2002; 
Croci et al., 2005). 
Contamination of water supplies can occur in areas that have not developed sewage 
disposal systems. Infection can occur from the consumption of contaminated water or even 
ice, or from uncooked food that is washed with this contaminated water (Koff, 1999; 
O'Grady et al. ,  2000; Brundage and Fitzpatrick, 2006). On the other hand, it can 
occasionally be transferred through parenteral routes, e.g. drug abuse if individuals are 
acutely infected with HA V (Aspinall and Taylor-Robinson, 2002). Some studies suggest 
that homosexual men are at increased risk of acquiring hepatitis A (O'Grady et al., 2000; 
Sonder et aI, 2006). Moreover, transmission of HA V through semen or vaginal secretions 
during sexual contact does not appear to be the significant route of infection (O'Grady et 
aI., 2000). 
Hepatitis A virus can be detected in blood, and viral transmission has been 
recognized using blood harvested up to 1 1  days before the onset of symptoms of infection. 
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It has al 0 been documented that hepatitis A may be transmitted to hemophiliacs' patients 
while receiving coagulation factors from pooled blood donors (O'Grady et al. , 2000; 
Mar hall, 2004). 
Hepatitis A virus is detectable feces or in blood (in relatively lower concentrations 
compared to feces), 2 weeks before the onset of jaundice and for up to 8 days afterwards. 
The high peak of infectivity progresses during this 2 weeks period. While infants and 
children can shed HA V for several months without any obvious symptoms called as "silent 
infection". Around 90% of the children less than 5 years of age with HA V infection are 
asymptomatic, while 90% of i nfected adults can experience symptoms like jaundice 
(O'Grady et al., 2000; Hollinger and Emerson, 2001; Marshall, 2004; Mims et al., 2004). 
The incubation period ranges from 2-6 weeks (Degre, 1989; Collier and Oxford, 1993; 
Conlon and Snydman, 2000; Marshall, 2004). 
1 .2.4. Morbidity and Mortality: 
Hepatitis A possibly infects cells in the gut initially and then spreads to the liver via 
the blood (Black, 2002; Bums, 2002). Clinical illness usually starts with a few days of 
malaise, loss of appetite, vague abdominal discomfort, and fever. Diarrhea is more 
common in children. Hepatomegaly and occasionally splenomegaly or rush, may occur. 
This stage called as Preicteric phase may last for 5-7 days. The color of infected person's 
urine becomes dark and the feces pale. Soon afterwards jaundice becomes apparent, fIrst in  
the sclera and then in the skin. This stage called as Icteric phase which may last from 4-30 
days. The symptoms and jaundice disappear approximately within a month, although, 
around 10-15% of the patients experience prolonged or relapsed disease for about 6 
months (Degre, 1989; Hollinger and Emerson, 2001; Aspinall and Taylor-Robinson, 2002; 
Marshall, 2004; Brundage and Fitzpatrick, 2006). However, only one third of the patients 
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with acute infection of hepatitis A are jaundiced (Ryder and Beckingham, 2001). Jaundice 
is caused by impaired liver function: when the liver fails to rid the body of a yellow 
substance called bilirubin, which is a product of the breakdown of hemoglobin from red 
blood cells (Black, 2002). 
Hepatitis A virus does not cause a chronic viral hepatitis like hepatitis B, but 
hepatitis A is considered as the most common viral hepatitis infection and a cause of 
significant morbidity and mortality (Damme and Bell, 200 1 ;  Almuneef et al, 2006). Fetal 
acute liver failure is one of the well-recognized complications of HA V infection, but 
luckily uncommon (Sacy et al, 2005). Some patients may have subsequent 'post viral' 
symptoms such as fatigue. Fulminant hepatitis is a life-threatening acute complication of 
HA V infection, but it is rare. The mortality is only about 1 1 1 000 (Collier and Oxford, 
1 993). A recent report predicts that the overall fatality rate is around 0 .3% (Brundage and 
Fitzpatrick 2006). Fulminant hepatitis is fortunately rare and overall, it can occur in less 
than 0 .3% of cases. The risk of HA V morbidity and mortality increases with age, if 
infection occurs after the age of 40 or 50 the mortality rate increases to about 2% or 3%, 
respectively (Aspinall and Taylor-Robinson, 2002; Brundage and Fitzpatrick, 2006). The 
majority of infections take place before the age of 5, with seroprevalence studies done in 
western societies suggesting prevalence between 40-70%. In keeping with improved public 
health, these rates seem to be falling since the prevalence of HA V is very closely 
associated to the socioeconomic condition of the population and can vary within the same 
country according to the changes in hygienic circumstances. In developing countries, like 
for example, most of the countries in the Middle East, are experiencing continuous 
improvement in socioeconomic status, and enter transition phase moving from high 
endemicity to the intermediate, and then to low one, with a delay in the average age of 
infection. One main outcome of this could be that the normally sub-clinical childhood 
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infection becomes less common, leaving non-exposed adults at risk of potentially more 
evere infection later in life (Aspinall and Taylor-Robinson, 2002, Sacy et al, 200S). 
In the United Kingdom HA V is responsible for 1 0%-20% of cases of liver failure 
disease and has an overall mortality rate of 0.1 %. While in the United States, 72% of 
patients with hepatitis A occurred in 2002 developed jaundice, and 2S% required 
hospitalization, with an associated mortality of O.S%. The case-fatality rate in that time was 
highest (1.2%) amongst persons aged 60 years old or more (Zuckerman et al., 200S). 
1.2.5. Diagnosis and Treatment 
Routine liver ftmction tests will show elevations, especially in the serum 
transaminases and bilirubin levels. However, there will also be an increase in 'cholestatic' 
markers such as alkaline phosphatase (Aspinall and Taylor-Robinson, 2002; Brundage and 
Fitzpatrick, 2006). In Alaska the results of liver ftmction tests helped local and state public 
health professionals to accurately predict the magnitude of an outbreak of hepatitis A 
occurred in January 2001 (Castro dale et al., 2002). 
Serum anti-HA V IgM more often can be detected from S-10 days before the onset 
of the symptoms, and the level of the IgM antibodies may remain high for 4-6 months. 
While anti HA V IgG levels start to rise shortly after the IgM level, the anti HA V IgG 
remains during the patient's lifetime (figure 4). In severe cases, a coagulopathy and 
hypoalburninaemia may occur (Aspinall and Taylor-Robinson, 2002; Brundage and 
Fitzpatrick, 2006) . 
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Figure 4: The immune response to hepatitis A virus (Forbes et aI., 2002). 
There is no specific therapy for HA V infection and the majority of cases require 
nothing more than supportive care with bed rest, adequate fluid intake, balanced nutrition, 
antipyretic measures and avoidance of alcohol. Immunoglobulin has a protective effect 
when given before or shortly after exposure to the infection. Those most at risk of 
complications (particularly the older age groups and those with pre-existing chronic liver 
disease) should be monitored closely (Degre, 1 989; Brundage and Fitzpatrick, 2006). Bed 
rest will be useful together with simple analgesics to ameliorate severe prodromal 
symptoms. Antiemetic and Antipruritic drugs may be helpful in convalescence, but for 
severe pruritis, cholestyramine is more effective. Corticosteroids can be used for the 
treatment of prolonged severe cholestasis (Bannister et al., 1 996). Most patients with 
hepatitis A infection have a self limiting illness and lifelong immunity is provided either by 
infection or vaccination (Ryder and Beckingham, 200 1 ;  Jacobsen and Koopman, 2004; 
Giammarino and Dienstag, 2005). 
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1 .2.6. Epidemiology 
Hepatitis A is an acute disease, caused by hepatitis A virus which is responsible for 
around 1.5 million cases an ually (Sacy et aI, 2005; Steffen et aI, 2005). Worldwide the 
endemicity of hepatitis A can be categorized into three major patterns, namely: low, 
intermediate and high. In developed countries the seroprevalence is low in all age groups; 
such as Canada which is considered as low endemic country. In such countries it is 
generally recommended to vaccinate those at risk e.g. the elderly (> 50 years old) who are 
more prone to serious disease and possibly death if infected with hepatitis A (Pham, 2005). 
On the other hand, in developing countries most of the population (> 90%) is 
infected during the fIrst years of life before 10 years of age and by the adulthood almost all 
the population is exposed and immune to hepatitis A (Letaief et aI, 2005; Sacy et al, 2005), 
as immunity to HA V is a lifelong one, there is no need to vaccinate against hepatitis A in 
high endemic areas (Jacobsen and Koopman, 2004; Letaief et al, 2005; Almuneef et al, 
2006). In between the above two endemicity patterns the HAV endemicity is intermediate 
in many countries witnessing progressive development in hygiene and sanitation e.g. East 
Europe, Russia, East Asia and some Middle East countries e.g. Saudi Arabia. The Middle 
East in general is considered as highly endemic with more than 95% of adults in many 
countries having been previously infected with hepatitis A, but the average seroprevalence 
of hepatitis A are falling (Jacobsen and Koopman, 2004). 
High rates of HA V infections are strongly associated wi� low income, low 
educational level, high crowding conditions and lack of access to safe drinking water and 
sanitation facilities. As socioeconomic status is improved the HA V infection rate declines 
in many areas of the world (Koff, 1999: lopez et al., 1999; Jacobsen and koopman, 2005). 
The level of sanitation or hygiene in the environment obviously affects the epidemiology 
of hepatitis A. Prevalence studies show that on population living in crowded areas with 
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poor or inadequate sanitation facilities, infections occur at an early age and around 100% 
of children acquire immunity during the fust decade of their l ives (Hollinger and Emerson 
2001). 
The mode of spread is  similar to other enteroviruses, i .e. mainly transmission is 
through the fecal-oral route (Collier and Oxford, 1993; Tosun et al., 2004; Letaief et al, 
2005). HA V can survive for long periods of time in sea, fresh water and soil. HA V can be 
re istant to freezing, detergent and acids, but can be inactivated by formalin and chlorine. 
Large quantities of virion can be excreted in the feces for several days before and after the 
onset of jaundice. Fecal excretion of viral particles start a few weeks before and last for at 
least 1 week after the onset of clinical illness. On the other hand fecal HA V excretion for 
months has been reported in infected neonates (up to 6 months); infection in children 
mostly initiates community-wide outbreaks. HA V can survive on human hands and vomits 
and for inactivation requires a temperature higher than 85°C (Collier and Oxford, 1993; 
Timbury, 1997; Koff, 1999; Brundage and Fitzpatrick, 2006). 
The prevalence of HA V varies from one region to another and it is connected 
mainly with the socioeconomic factors and living standards of the population (Kalaajieh, 
2000; Jacobsen and koopman, 2004). Hepatitis A is mostly widespread in countries where 
sewage treatment and hygiene are generally poor, and most persons acquire the disease as 
a subclinical (asymptomatic) infection in  early childhood (Hollinger and Emerson, 2001; 
Jacobsen and koopman, 2004). 
Hepatitis A infection has varied geographic distribution, with areas of high 
endemicity especially in developing countries and in some native populated areas in the 
United States. Generally, USA and Australia have low rate of anti-HA V (Jacobsen and 
koopman, 2004). 
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The overall prevalence of hepatitis A in the United States is around 33% as 
reported in 1999. Among reported cases 50% were without identified risk factors (Koff, 
1999). In addition, hepatitis A is considered as one of the most common causes of 
infectious jaundice worldwide. The total number of cases of viral hepatitis A reported in 
1998 to the National Notifiable Diseases Surveillance System done by the Centers for 
Disease Control and Prevention was 23,229 yielding a rate of about 8.59 cases per 100,000 
population. A downward trend is seen in the hepatitis A rates since 1995. The rates of 
disease are mainly high among children, young adults, in American Indians! Alaskan 
Natives and Hispanics as shown in the figure 5 (Hollinger and Emerson, 2001). 
Asianl 
��iflc Isl-'nder 
Black White American IndIan! H ispanic 
Alas kan Natlve 
RAC E/ETH NIC rTY 
Figure 5: Rates of reported hepatitis A cases (per 100,000 inhabitants) in the United States 
in 1997, by race!ethnicity (Hollinger and Emerson, 2001). 
In another study done in USA, where 21,260 blood samples collected in 1988-1994 
(before the availability of HA V vaccine commercially) were tested for HA V antibody. The 
participants were 6 years of age or older and from different ethnicity backgrounds. The 
overall prevalence was 31.3% and age was the most strongly associated factor with 
prevalence which increased when the subject's age increased. The prevalence of infection 
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was signi ficantly higher within foreigners compared to US-born subjects while was highest 
among Mexican-American and lowest among non-Hispanic Whites. During samples 
col lection before the corrunercial introduction of HA V vaccine, the most important factors 
to determine HA V infection in USA were age, ethnicity and birthplace (Bell et aI . ,  2005). 
There was recent decl ine in the incidence of yearly reported new cases of hepatitis 
A infection in the United States. In 1 980s and 1 990s an average annual incidence was 
28,000 ca es (9 to 1 4  cases per 1 00,000 population) which was reported to the Centers for 
Disease Control and Prevention, but declined to the lowest ever recorded 7600 cases 
annually (2 . 7  cases per 1 00,000 population) in 2003 (Giammarino and Dienstag, 2005). 
In Austral ia, in the years 1 999 and 2000, there were 2327 reported cases of 
hepatitis A. The highest incidence rate of infection in the age group of 1 5-24 years was 
9 .31 1 00 000, fol lowed by age groups 5- 1 4  years old (8/ 1 00 000) and 0-4 years old 
(6.6/1 00 000). The incidence rates of disease in age groups above 24 years were lower than 
the average incidence rate in the general population. In 1 999 and 2000 hepatitis A 
accounted for an average of 4 1 62 hospital bed days per year (Macintyre, 2003). 
In Lebanon, as an example of a country from the Middle East region, a survey was 
done in 2000 when the researchers concluded that the high overall HA V prevalence in 
chi ldren proves that North Lebanon is considered to be an intermediate endemic area for 
HA V infection. Like many countries in the world and because of the improvement in 
hygiene and sanitation, the introduction of hepatitis A vaccination in early childhood can 
reduce the prevalence of HA V infection and prevent outbreaks in future (Kalaaj ieh et al, 
2000). Another study was done in Lebanon on 606 subjects aged from 1 -30 years in 2005, 
where hepatitis A virus seroprevalence were surveyed by age, gender and socio-economic 
condition. This study showed that age was the most important factor affecting HA V 
seroprevalence. HA V seroprevalence ranged from 78% in adults >20 years of age group, 
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1 1  % in 1 -5 years age group indicating a decl ine in HA V seroprevalence in younger age 
groups compared to adults. Therefore, the researchers concluded that including hepatitis A 
vaccine in the schedule of routine childhood vaccinations should be considered (Sacy et 
al . , 2005). 
study done in Turkey reported a shift of seropositivity from children to 
adolescents particularly within famil ies with an average or high socio-economical status 
(Tosun et al . ,  2004) . The overall prevalences of HA V antibodies in Turkey were reduced 
from around 90% to 72 .3% during the last 2 decades (Jacobsen and koopman, 2004). 
In Africa and the Middle East the data on the endemicity of hepatitis A virus 
(HA V) infection are rare, but most of the African countries appear to remain high endemic 
regions, with the exception of subpopulations in some areas for example: White people in 
South Africa (Tufenkej i ,  2000; Jacobsen and koopman, 2004). Saudi Arabia is a good 
example for the Middle East countries especially Gulf council  countries l ike UAE, and is a 
country in which a shift of HA V seroprevalence has been reported in recent years, 
reflecting the socio-economic development that has taken place over the last two decades. 
Earlier studies generally showed very high prevalence because most people become 
infected in early chi ldhood. Between 1 989 and 1 995 there was a significant fal l  in the 
seroprevalence of antibodies to HA V in chi ldren up to 1 2  years old (by almost 50%) 
throughout the country except in one region bordering Yemen. Seroprevalence was 
connected to socioeconomic status of the individual, being highest in the lowest groups. 
Recently seroprevalence surveys of anti-HA V in Saudi Arabia demonstrated a shifting 
pattern from high to intennediate or low endemicity of HA V seroprevalence (Tufenkej i ,  
2000). 
A recent study in Saudi Arabia in the year 2006, aimed at detennining the 
seroprevalence of hepatitis A within selected groups of Saudi children, from 4- 1 8  years old 
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(2399 subjects) in order to, identify the best immunization strategy. Quantitative Hepatitis 
vi rus antibodies were measured by means on Enzyme linked immunosorbent assay 
(ELI ) using Axsym HA V ab.2.0 system (Abbott diagnostic division). The overall 
prevalence was 28 .9% and the rates were gradually increasing with age. As the prevalence 
of HA V is closely l inked to the level of development in socio-economic status and l iving 
standard it is  expected that more decl ine in HA V infection may occur in Saudi Arabia. In 
that study as in  the previous studies, the group of Researchers recommended inclusion of 
hepatitis A vaccine in the schedule of routine chi ldhood vaccinations (Almuneef et ai , 
2006). 
1 .2.7. P revention a n d  Contro l  
Because no specific effective treatments are available against HA V infection, 
preventive measures are most important to control the disease. Good sanitation and 
personal hygiene are most effective preventive measures for hepatitis A. Suitable facilities 
for hand-washing and sanitary disposal of faeces are very important, especial ly in nurseries 
and schools were spread is l ikely to occur. By proper education of food-handlers and 
suitable cooking of foods (such as shellfish) the risk of common-source outbreaks can be 
minimized (Bannister et al . ,  1 996). 
As a prophylaxis, specific anti-HV A immunoglobulin confers passive immunity 
(provide short term protection from 3-5 months) and if administered intramuscularly 
within two weeks of exposure to hepatitis A wil l  yield 69-89% effective prevention against 
symptomatic infection (Brundage and Fitzpatrick, 2006). More effective option is one of 
the inactivated virion-based vaccines which gives long-lasting immunity to HA V. Some 
proprietary formulations combine protection against typhoid or hepatitis B with 
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immunization against HAV which offers a reduction of costs associated with vaccine 
administration (Aspinall and Taylor-Robinson, 2002 ; Brundage and Fitzpatrick, 2006). 
Those at risk, such as travelers from low endemic areas to highly endemic areas, 
staff and patients of hospitals or institutions for the mental ly handicapped, an inactivated 
accine is now avai lable. One dose injected intramuscularly, with optional booster dose 6-
1 2  months later. A single dose gives immunity for a year; two doses give 1 0  years 
protection. Mostly mild reaction at site of infection is the side-effect (Timbury, 1 997). 
Hepatitis A vaccine is routinely given in regions with high disease incidence but, it 
is not yet recommended for al l infants in the U.S. In the United States each year there are 
1 80,000 infections, 90,000 symptomatic cases, and 1 00 deaths because of hepatitis A. 
Most deaths occur in two main groups, persons older than 50 years of age and in 
individuals with chronic l iver disease. In addition 22% of patients are hospitalized; the 
average work lost is 27 days. In 1 997, the overall costs due to hepatitis A in the United 
States exceeded $300 mi l lion (Marshal l ,  2004). 
In the United States two vaccines are available and the trade names are Havrix and 
V AQTA. Both vaccines consist of chemically inactivated hepatitis A virus which grows on 
MRC-5 (human diploid) cells and adsorbed to alum (Bovier et aI , 2005;  Marshal l ,  2004). 
Other components of the final preparation of the vaccine possibly include amino acids, 
polysorbate 20, residual cellular proteins and DNA, formalin or formaldehyde, bovine 
albumin, sodium borate, and sodium chloride. Both vaccines are recommended and labeled 
for pre-exposure prophylaxis against hepatitis A virus infection in persons with 2 years of 
age or older (Marshal l ,  2004). 
In 2005, a total of 5 vaccines were avai lable against hepatitis A. Two inactivated 
hepatitis A vaccines were approved for use in many countries in the world, including the 
United States. The vaccine is l icensed to be used for chi ldren aged 1 year or older, while in 
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the United tates the vaccine is l icensed for children aged 2 years or older. Another two 
inactivated vaccines are l icensed to be used in Europe, Canada, and in other countries 
around the world. One live-attenuated hepatitis A vaccine is presently used in China. 
Results from cl inical trials and post-marketing studies have demonstrated many advantages 
with using all of the above mentioned vaccines which are: safe, wel l-tolerated, and highly 
immunogenic, conferring protective immunity against the disease 2 to 4 weeks after the 
first dose. Administration of the second dose (6- 1 8  months after the first dose) wil l  
guarantee long-term protection. Protective efficacy of  all of  these vaccines range from 85% 
to 1 00%. Hepatitis A vaccine was originally recommended for high-risk groups only, but is 
now used universal ly or added to existing mass chi ldhood or adolescent vaccination 
schedule programs in some specific areas of intermediate endemicity in the world (Damme 
and Herek 2005). In the United States the Center of Disease Control (CDC) recommends 
that the fol lowing persons are at increased risk for hepatitis A and should be routinely 
vaccinated: Persons traveling or working in intermediate or highly endemic countries, 
i llegal drug users, researchers working with hepatitis A virus-infected primates or with 
hepatitis A virus, persons who have clotting-factor disorders, persons who have chronic 
l iver disease, military personnel, employees of day care centers, food handlers and sewage 
plant workers. 
In 2006, the Advisory Committee on immunization Practices (ACIP), which 
frequently and periodical ly reviews the childhood immunization schedule, has 
recommended to implement hepatitis A vaccination to al l children starting from second 
year of l ife (Almuneef et al . ,  2006; Brundage and Fitzpatrick, 2006). 
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1.3. Hepatitis A in UAE 
Previously al l types of viral hepatitis were reported as one entity in U.A.E. but, 
smce 1 993 most of the medical districts started to report the disease according to the 
specific causative agent. There had been an apparent increase in the frequency of 
occurrence of iral hepatitis (al l types) in the UAE until 1 995 , which was 1 1 4 .3  per 
1 00 000 popUlation and then, it started to decline in 1 996 to 92.9 per 1 00,000 population. 
In 1 995 the total number of reported cases of hepatitis A in AI Ain medical district were 
1 6 1  (local=75, non-Iocal= 86) out of 770, which was the total number from 9 medical 
districts. In 1 996 the total number of reported cases of hepatitis A in AI Ain medical 
district were 2 1 9  (local= 1 1 0, non-Iocal= 1 09) out of 932, which was ,the total number from 
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Figure 6: Shows the incidence rate per 1 00,000 inhabitants of al l types of viral hepatitis in 
UAE from 1 987- 1 996 (Ncor, 1 996). 
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Figu re 7 :  Shows the distribution of reported cases according to the type of hepatitis in 
UAB in 1 996 (Noor, 1 996). 
Age-G rou p  
Ty pes 0- I - s- 1 5- 25- 35- 55+ Total 
H ep . .-\. I 1 24 4 5 5  1 3 2  86 1 24 1 0  932 
H ep. B " 1 2  36 I I I  3 8 9  464 66 1 08 1  J 
H cp. C 0 0 " I I  5 1  1 47 1 7  229 .) 
Others 0 6 3 1  4 9 6 4 60 
Total  4 1 42 525 258 535 741 97 2302 
Table 2 :  Shows the distribution of all types of viral hepatitis in UAB by age in 1 996 (Noor, 
1 996). 
In 1 997, the total number of reported hepatitis A cases in AI Ain medical district 
were 1 34 ( local= 43,  non-Iocal= 9 1 )  out of 66 1 ,  the total number from 9 medical districts. 
In 1 998 the total number of reported hepatitis A cases in Al Ain medical district were 1 54 
(1ocal= 43,  non-local= 1 1 1 ) out of 57 1 ,  the total number from 9 medical districts (Noor, 
1 998). 
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F igure 8 :  Shows the distribution of reported cases of al l types of hepatitis in UAB in 1 998 
(Noor, 1 998). 
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In 1 999 the total number of reported hepatitis A cases in AI Ain medical district 
ere 345 (Iocal= 264 non-local= 8 1 )  whi le, in 2000 total number of reported hepatitis A 
cases in Al Ain medical district were 59 (local= 26, non-local= 33) (Noor, 2000). 
In 200 1 the total number of reported hepatitis A cases in AI Ain medical district 
were 59 ( Iocal= 28,  non-Iocal= 3 1 )  (Neer, 200 1 ) . 
Incidence rate of Hepatitis " A" in AI Ain 
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Figure 9 :  Shows the incidence rate for hepatitis A in AI Ain medical district from 1 995-
2005 (modified from Noor, 200 1 ). 
According to the preventive medicine in Ministry of Health in UAE, in 2002 the 
total number of hepatitis A cases were 375 with an incidence of 1 01 1 05 population. The 
most affected age group in the same year was from 5- 1 4  years with an age specific 
incidence rate of 30 .81 1  05 population. 
Abu Dhabi medical district showed the highest incidence of the disease in 2002 
with an IR= 1 5 .61 1 05 population followed by AI Ain and Sharjah. The total number of 
hepatitis A cases in AI Ain medical district in 2002 were 60 (local= 36, non-local= 24) out 
of 375 ,  which was the total number from 9 medical districts. UAE citizens constituted 52% 
of the total hepatitis A cases in 2002, see table 3 (Neer, 2002). 
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Age group 
T otal I R  
MedicBI District 0- I - s- 1 5- 2 5- 35- 45+ 
Abu Dhabi  1 22 90 1 8  7 3 1 142 1 5.6 
W .  Region 0 0 0 0 0 0 0 0 0.0 
A l A i n  0 1 2  34  1 0  I 0 3 60 12.8 
Dubai  0 5 20 25 1 7  8 8 83 7.5 
Sharj a h  0 3 3 5  1 2  5 1 4 60 . 10.0' 
IAj man 0 3 4 I :2 1 1 1 1 . 5:6 
U A Q  0 0 4 0 0 0 0 4 6.8. 
RAJ( 0 0 3 1 0 1 3 g 4.3 
Fujairah 0 I 5 0 0 0 0 6 . ,5.4 
Total 1 -46 195 67 32 14 20 375 . 1 0.0 
I n cidence Rate 1.7 1 7.5 30.S. · 1 1 .6 3.2 1 .8 4:7 ' 
. . . 
1 0.0 . 
Table 3 :  Shows the age distribution of reported hepatitis A cases in 2002 in the 9 medical 
districts of UAE (Noor, 2002). 
In  2003, the total number of reported hepatitis A cases in  Al Ain medical district 
were 60 (local= 26, non-Iocal= 34) out of 326, which was the total number from 9 medical 
districts in the same year (Noor, 2006) . 
In 2004, the total number of reported hepatitis A cases decreased in AI Ain medical 
district were 45 ( local= 23 ,  non-Iocal= 22) (Noor, 2006) . In 2005, the total number of 
reported hepatitis A cases in Al Ain medical district were 56 ( local= 24, non-Iocal= 32) 
(Mr. Ismail AI Raisi, Al Ain Preventive Medicine, personnel communication). 
In United Arab Emirates, the last study for hepatitis A virus seroprevalence was done 
in 1 995,  which aims to investigate the seroprevalence of HA V, HEV, HeV and HEV in 
the UAE army. The army includes all socio-economic groups and was drawn from every 
geographic region of the UAE. 1 009 serum samples which included 466 officers and 543 
soldiers (902 men, age range 1 5-49 years, mean age 23 years; 1 07 women, age range 1 7-39 
years, mean age 24.9 years). The results for HAV-IgG were 93 .5% for men, 93 .5% for 
women, 95. 1 %  for officers and 92. 1 %  for soldiers. This result shows that HA V was 
endemic in the UAE army (Albioushi, et aI, 1 995a). Another study by the same researcher 
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was reported in 1 995 . 1 583 samples were obtained from the volunteers ( 1 1 57 men and 426 
omen) ith completed questionnaire. These groups consisted of both mil itary and 
ci i l ian population distributed uniformly between al l ranks and socio-economic groupings. 
Al l  serum samples were tested for total immunoglobulin using an ELISA technique 
(Abbott Diagnostics, USA). 1 227 from the total samples tested positive for HA V-IgG 
gi ing an overal l seroprevalence of 77 .5% in the UAE. The prevalence were higher in 
males (83 .8%) than in females (60.3%) The researchers concluded that HA V 
seroprevalence in UAE was high but probably decreasing because of improvement in 
living standards and because of this reduction in seroprevalence of HA V, the risk of 
cl inically significant HA V infection in adulthood is increasing and may cause high rate of 
morbidity and mortal ity. 
Final ly, they recommended commencing a vaccination program against hepatitis A in 
UAE (Albloushi , et al, 1 995b). 
1.4. Objectives 
1 .  To determine the seroprevalence of hepatitis A in Al Ain city m chi ldren, 
adolescents and adults in UAE nationals and expatriates. 
2 .  Based upon the results o f  the seroprevalence o f  hepatitis A ,  a need for vaccination 
against hepatitis A may be apparent. 
3 .  To fmd out, to which epidemiological setting, Al Ain city belongs i .e . ,  low, 
medium or high prevalence in relation to the continuous improvement in living 
standards, hygiene and sanitation. 
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II. MATERIALS & METHODS 
II. MATERIALS & M ETHODS 
1 1. 1 .  Subjects and Methods 
1 1 . 1 . 1 .  Study area : Al AiD City 
Al Ain is the Eastern region of Abu-Dhabi bordering Oman .  AI Ain city is about 
1 65 km from Abu Dhabi and 1 40 km from Dubai. AI-Ain region, covers an area over 1 . 1 7  
mil lion hectares. It mostly has sand dunes and the temperature during the year ranges 
between 1 0°C up to 48°C. Al Ain city is considered as the country's centre of learning, 
housing the UAE University and famous for its tourist destinations. The city is divided into 
3 5  district areas; see the map below (Al Ain Town Planning department, 200 1 ). 
The main reason for choosing the AI Ain city, as the area of study, was because this 
city reflects the remarkable progress in UAE. In 1 997 Al Ain city won the second rank 
(after Westminster in UK) in the international competition 'Nations in Bloom'.  This 
competition was to promote and recognize the main value of investing in landscape of 
towns and cities, especially, in the social environment and positive impacts on the quality 
of l ife (AI Ain Municipality, 1 997). Therefore, Al Ain can be a good example to study the 
impact of improvement in the socioeconomic and living standards on the prevalence of 
hepatitis A.  
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Figure 1 0 :  AI Ain city map (Engineering Yahya Ahmad, Al Ain Town Planning 
department, personal communication). 
n. 1 .2. Study Design 
We hypothesized that: during the last 3 decades, the continuous and remarkable 
progress of UAE in various aspects of l ife particularly hygiene and sanitation should have 
lowered the endemicity of hepatitis A among UAE nationals from high to intermediate 
one. Due to the time l imitation, a simple random cross-sectional study design, rather than a 
random stratified design, was adopted based on the two population inhabitants of Al Ain 
city namely, UAE nationals and expat.riates. The minimum number of required samples 
was based on sampling from large population with 99% confidence level and 1 0% margin 
of error of an expected HA V prevalence of 60% (intermediate endemicity) and 90% (high 




s = the sample size 
z = 2 .58  for 99% Confidence level .  
s = Z2 [p(1-p)] 
e 2  
p = an estimate of the proportion of HA V positive subjects (60% for UAE nationals and 
90% for e patriates). 
e = the margin of error we were prepared to accept ( 1 0%) (Kirkwood and Sterne, 2003). 
The minimum required number of subjects was found to be 1 60 for UAE nationals and 60 
for the expatriates group. 
I I . 1 .3.  Study Population and Blood Sampling 
The study comprised two populations, the UAE nationals group and an expatriate 
one. The latter included mainly Egyptians, Indians, Pakistanis and some other nationalities. 
Both groups were inhabitants of Al Ain city. The first group was enrol led randomly in the 
study among outpatients of Tawam hospital and Al Jahli clinic; they came for treatment of 
any disease other than hepatitis and diagnosis of their i l lness required a blood sample. A 
total of 280 subjects were sampled covering the age range from 0-39 years of age. 333  
expatriates in the same age range were sampled from outpatients attended the primary 
health care cl inics in Al Ain, namely Ood Al T oba and AI Khabisi using the same criteria 
for selection as for the UAE nationals group. 
Blood sampling was carried out between February (2004) to May (2005) .  From 
each subject 3 rnl of blood was obtained in a plain tube with separator gel and the serum 
was separated on the same day, centrifuged immediately for 1 5  minute at 3000 rotation per 
minutes (rpm), and stored at -30°C unti l used. On the same day of analysis, each batch of 
serum was thawed at room temperature and mixed wel l  using a vortex. The samples were 
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centrifuged agam for 1 5  minutes at 3000 rotation per minutes (rpm) before testing to 
remo e any particulate matter and to ensure consistency in the results. The experimental 
work was carried out in Tawam hospital as the "AxSYM system" is avai lable at the 
Cl inical Laboratory, Tawam hospital .  
For each subject, a questionnaire was filled at the time of blood sampling. It 
included inquiries on age sex, national ity education, occupation, number of family 
members, number of bedrooms, crowding category [(calculated by dividing the number of 
fanllly members over the number of bedrooms to give the crowding index), the latter 
grouped into 3 crowding categories namely > 0- 1 = low, > 1 -2 intermediate and > 2 high] , 
presence of housemaid (only for UAE nationals), history of jaundice and history of 
international travel ( if yes where and when) (see appendices). 
I I . 1 .4 Ethical aspects 
The study obtained an ethical clearance from the research review committee at 
Tawam Hospital in January 2004. According to the instructions of the committee, the name 
of the subject was not included in the questionnaire form in order to safeguard the privacy 
of the participants. In addition, a consent form was signed by the participants or their 
guardians and we briefly explained to them the benefits of the study before withdrawing of 
samples (see appendices). 
I I . I .S. Methods 
1 1 . 1 .5. 1 .  Reagents 
A widely adopted standardized method from Abbott known as the AxSYM system 
HA V AB® 2.0 which is a microparticle enzyme immunoassay (MElA) was used for the 
detection of total antibodies for hepatitis A virus (HA V) in human serum. 
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The reagent pack of HA V AB 2.0 was enough for 1 00 tests. It consisted of two 
bottles enclosed in the same pack. Reagent bottle 1 contained 1 l . 7 1  ml of antibody to 
hepatiti A virus antigen (human) : alkal ine phosphatase conjugate in TRlS buffer with 
protein stabilizers . Minimum concentration was 1 . 5 Ilglml and antimicrobial agents were 
included . Reagent bottle 2 was containing 3 .45 ml hepatitis A virus (human) coated 
microparticles in TRIS buffer with protein stabi lizers. Minimum concentration was 0.05% 
ol ids. Index calibrator was prepared in fetal bovine serum with 8 rnl volume. Fetal bovine 
serum constituted the negative control and purified anti-HA V (human) prepared in fetal 
bo ine serum comprised the positive control . .  All the above reagents were preserved in 
sodi um azide. 
I I . 1 .S.2. Description of Experimental Procedure 
On the same day of analysis, al l sera were thawed at room temperature and mixed 
wel l  by using a vortex. The samples were centrifuged before testing for 1 5  minutes at 3000 
rotation per minute (rpm) to remove any particulate matter and to ensure consistency in the 
results. 
The samples were placed in batches in the Axsym machine for analysis. The 
Axsym HA V AB 2 .0 reagents and samples were added in certain sequence. In sampling 
center, samples and hepatitis A virus (human) coated microparticles were combined in one 
reaction vessel (RV). When anti-HAV is present in the sample, it binds to the hepatitis A 
virus (human) coated microparticles, forming an antigen-antibody complex. The reaction 
vessel was inunediately moved to the processing center. In the processing center, a portion 
of the reaction mixture was transferred to the matrix cel l .  The microparticles bond 
irreversibly to the glass fiber matrix .  After that, alkaline phosphatase conjugate was added 
onto the matrix cel l  to bind with the HA V antigenic sites on the microparticles which were 
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not bound with anti-HA V from the sample. Then the matrix cell was washed with matrix 
cell wash to remove the extra materials which did not bind to the microparticles. The 
ubstrate (4-Methylumbell iferyl Phosphate) was added . The alkal ine phosphatase-labeled 
conjugate catalyzes the removal of a phosphate group from the substrate, to give the 
fluore cent product, 4-Methylumbell iferyl; this fluorescent product was measured by the 
MElA optical assembly. The presence or absence of the anti-HA V in the serum samples 
was determined by comparing the rate of formation of fluorescent product to a cutoff rate 
which was calculated from a previous Axsym HA V AB 2.0 index cal ibration. If the rate of 
formation of fluorescent product in the serum sample was less than or equal to the cut off 
rate the sample was considered reactive for anti-HAY. 
1 1 . 1 .5.3. Biological Principles of the Procedure 
AxS YM HA V -Ab is based on Microparticle Enzyme Immunoassay (MElA) 
technology and util izes the principle of competitive binding between anti-HA V in the 
sample and anti-HA V (Human) alkaline phosphatase conjugate for the HA V antigen 
coated on the microparticles. When anti-HAV is present in the sample it binds to the HA V 
(Hum an) coated microparticles, forming an antigen-antibody complex in the reaction 
matrix .  After washing, Alkal ine Phosphatase conjugate is dispensed onto the matrix cell 
and binds with the HA V antigenic sites (unbounded) on the microparticles. The substrate 
4-Methylumbell iferyl Phosphate (MUP) is added, the alkaline phosphatase labeled 
conjugate catalyzes the removal of phosphate group from the substrate yielding the 
fluorescent product. This product is measured by the MElA optical assembly. The presence 
or absence of anti-HA V in the sample is determined by comparing the rate of formation of 
fluorescent product to a cutoff rate which is calculated from a previous AxSYM HA V AB 
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2.0 Index calibration. A positi e control and a negative control were included along each 
batch of sample run .  
I I .  1 .5.4. Quality Control 
a- Calibration 
minimum of two replicates of the Axsym HA V AB 2 .0 index calibrator must be 
te ted for an Axsym HA V AB 2 .0 calibration. A single sample of both negative and 
positi e control must be tested as a means evaluating the assay calibration. Once an Axsym 
HA V AB 2 .0 calibration was accepted and stored, al l samples can be tested without further 
cal ibration. 
b- Quality Control  
The minimum control requirement for an Axsym HA V AB 2.0 assay was a single 
sample of each of the negative and positive control tested once for each sample batch. Both 
controls should be within the acceptable range which was for negative control from 1 .400 
to 2 .600 and for positive control was < or = 0.900. 
c- Calculation 
The Axsym system calculated the mean rate of index calibrator replicates and 
stored the result. The cutoff rate (co) = Index calibrator mean rate/2, then Axsym system 
protocol calculated the results of the samples based on the ratio of the sample rate (s) to the 
cutoff rate (co) for each sample and control, al l this process was done automatical ly by the 
Axsym system software related to the HA V AB 2.0 assay protocol . 
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I I . 1 .S.S. tati tical analy is 
Data were analyzed on a personal computer, using SPSS Package version 1 3 .0 .  To evaluate 
the factors associated with HAV exposure as measured by anti HA V total antibodies, 
binary logistic regression was employed to calculate the odds ratios (OR). Multiple logistic 
regre sions were employed to estimate which factor (s) among those found statistically 
significant in binary logistic regression was (were) independently associated with hepatitis 
A exposure. (Pearson Chi square (X2) analysis was used to test for differences in 
proportions between two or more variables, whereas for ordinal variables namely age, 
education and crowding category l inear by l inear test was used. P values < 0.0 1 were 
considered statistical ly significant. 
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III. RESULTS 
III. Resu lts 
111. 1 .  Preface 
The subjects of th i s  study were chi ldren, adolescents and adu lts of two d ifferent 
popu lations namely OAE nationals (n = 280) and expatriates (n =333 ) i nhabitants of Al Ain c ity. 
The two populations are ethnically d istinct as OAE nationals were predominantly Arabs, whereas 
the expatriate subjects were heterogeneous from 24 d ifferent countries: predominantly from East 
Mediterranean and South-East Asia., and few from West Pacific, Europe and Africa. The m ixing 
between the two populations i s  min imal as marriage among OAE nationals i s  predominantly intra­
marriage; moreover, UAE nationals in general have d ifferent social habits, h igher income and 
better standard of l iv ing compared to expatriates. Therefore, this study investigates mainly the 
effects of improvement in the standard of l iv ing particularly hygiene and san itation, in Al Ain city, 
as a representation for OAE in general on the prevalence of hepatit is A; in the subsequent sections 
of th i s  chapter, we analyzed the data from UAE nationals and expatriates separately. A section was 
devoted to UAE nat ionals, another section to expatriates and a th i rd one to compare demographic 
and serological data in the two studied groups. 
111.2. UAE Nationals 
III.2. 1 .  Sample characteristics 
A total of 280 UAE nationals were included in the study. Based on our assumption 
of fall ing prevalence of HA V in Al Ain among UAE nationals from high to intermediate 
endemicity, we assumed that the overall prevalence would be about 60%. Consequently, 
the fol lowing formula was used: 




e = margin of error (the margin of error we were prepared to accept = 1 0% in this study). 
s = the sample size (= 280 in this study). 
z = 2 . 58  for 99% confidence leve 1 .  
p = an estimate of  the proportion of  people exposed to HA V in the population (= 60% in  
this study) (Kirkwood and Sterne, 2003) .  
I I I .2.2.  Vaccination against hepatitis A in UAE nationals 
Assessment of hepatitis A vaccination was done by randomly questioning 340 
outpatients of Tawam Hospital, if they had been vaccinated against hepatitis A. Only two 
persons (0 . 59%) answered yes. The negligible number of vaccinated subjects indicated that 
the anti HA V antibodies measured in our study were indicators of natural exposure rather 
than vaccination. 
I I I .2.3. Questionnaire data and HA V serology 
The age range was 0-39 years with a mean ± standard deviation of 1 9 .4 1 ± 1 0 . 5 1 .  
The distribution of the 280 subjects according to age showed that the number of subjects in 
the age groups 1 0- 1 4  and 3 5-39 years was small [ 1 9  subjects each (6.79% of the total)] as 
i l lustrated in Figure 1 1 . 
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Figure 1 1 : Distribution of UAE national subjects in age groups of 5 years. 
Therefore, subsequent analysis were done on the basis of grouping chi ldren in the 
rust decade of l ife in one age group (0-9 years), older chi ldren and adolescent in another 
age group ( 1 0- 1 9  years) and adults in a third age group (20-39 years). 
Figure 1 2  represents the distribution of UAE nationals according to age and anti 
HA V antibodies. The distribution showed a clear difference; children in the rust decade of 
l ife have low prevalence ( 1 6 .9%) in contrast with old children and adolescents (53 .7%) and 
adults > 20 years of age (9 1 . 6%). 
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Figure 1 2 :  Distribution of UAE nationals according to age groups and exposure to 
hepatitis A. 
The distribution of UAE nationals according to gender and hepatitis A exposure is  
presented in Figure 1 3 . Males had significantly lower sero-positive (3 1 . 7%) compared to 
females (75 . 1 %) .  




Figure 1 3 :  Distribution of UAE nationals according to gender and anti HA V antibodies. 
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However, 6 1 .9% of the males and 1 4 .7% of females were children in the first 
decade of life and an opposite trend was observed for the adults' age group as shown in 
Figure 1 4 . Generally females constituted the majority (77.5%) of the subjects as the 
amples were obtained from outpatients of Tawam Hospital and Al lahili clinic, where 
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Figure 1 4 : Distribution of UAE nationals according to gender and age groups. 
The distribution of all demographic parameters namely, age, gender, subject 
education, occupation, crowding category, presence of housemaid, history of jaundice, 
history of international travel and time since the last travel are presented in Table 4. 
Subject education was categorized into 6 groups and occupations into three groups, 
for both variables, preschool children were excluded from regression analysis (Table 4). 
In addition to age and gender (illustrated in Figures 1 2  and 1 3  above) subject 
education and occupation were also significantly associated with hepatitis A exposure. For 
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both parameters preschool children were excluded from odd ratio calculations as they were 
not supposed to have education or job. The other demographic parameters weren't 
statistical ly significant as shown in Table 4. 
Table 4 :  Distribution of demographic parameters and crude odds ratio (OR) for hepatitis A 
exposure with 99% confidence intervals in UAB nationals. 
Demographic Freq uency Seronegative Seropositive OR (99% CI) P 
cha racteristic n (%)d n (%)e n (%)" 
Age 
0-9 7 1  (25 .4) 59 (83 . 1 )  1 2  ( 1 6.9) 1 8  
1 0- 1 9  54 ( 1 9 .3) 25 (46.3) 29 (53 .7) 5.70 ( 1 .94- 1 6.74) <0.001 
20-39 I S S (55.3) 1 3  (08.4) 1 42 (9 1 .6) 53 .7 1 ( 1 7.78- 1 62.25) <0.00 1 
Gender 
Male 63 (22.5) 43 (68 .3)  20 (3 1 .7) I • 
Female 2 1 7  (77 .5) 54 (24.9) 1 63 (75 . 1 )  6.49 (2 .90- 1 4 .53) <0.00 1 
Subj ects Ed ucation:  
Pre-school b 44 ( 1 5 .7) 38 (86.4) 6 ( 1 3 .6) 
Primary 50 ( 1 7 .9) 29 (58 .0) 2 1  (42.0) 1 8 
Intermediate 52 ( 1 8 .6) 9 ( 1 7 .3) 43 (82.7) 6.60 ( 1 .99-2 l .87) <0.00 1 
Secondary 48 ( 1 7. 1 )  1 0  (20.8) 38  (79.2) 5 .25 ( 1 .6 1 9- 1 7 .0 1 )  <0.00 1 
University 76 (27. 1 )  1 0 ( 1 3 .2) 66 (86.8) 9. 1 1  (2.90-28 .6 1 )  <0.001 
I l l iterate 1 0  ( 3 .6) I ( 1 0.0) 09 (90.0) 1 2 .43 (0.75-207.20) 0 .02 1 
Occu pa tion : 
Student 88 (37.3) 44 (50.0) 44 (50.0) I 8 
Employee 49 (20.8) 4 ( 8.2) 45 (9 1 .8) 1 1 .25  (2.63-48 .05) <0.001 
House-wife or 99 (4 1 .9) 1 1 ( 1 1 . 1 )  88 (88 .9) 8 .00 (2.97-2 1 .53) <0.00 1 
unemployed 
Crowding Category: 
1 8 Low SO ( 1 7 .9) 1 9 (3 8.0) 3 1  (62.0) 
intermediate 1 66 (59.3) 57  (34 .3)  1 09 (65 .7) 1 . 1 7  (0.50-2.77) 0.635 
High 64 (22.9) 2 1  (32.8) 43 (67.2) 1 .26 (0.45-3 .47) 0.565 
Housemaid 
No 64 (22.9) 4 1  (64 . 1 )  2 3  (35 .9) I 8 
Yes 2 1 6  (77 . 1 )  1 42 (65 .7) 74 (34.3) 0.93 (0.43- 1 . 1 0) 0.804 
Jau n d ice: 
0 266 (95 .0) 92 (34.6) 1 74 (65 .4) I • 
Yes 1 4 ( 5 .0) 5 (35 .7) 9 (64 .3) 0.95 (0.22-4 . 1 6) 0.93 1 
I nternational  T ravel: 
No 1 1 0 (39.3) 45 (40 .9) 65 (59. 1 )  1 8 
Yes 1 70 (60.7) 52 (30.6) 1 1 8 (69.4) 1 .57 (0.8 1 -3 .03) 0.077 
Time of T ravel c:  
<2 Years 63 (37. 1 )  25 (39.7) 38  (60.3) 1 • 
>2 Years 1 07 (62.9) 27 (25.2) 80 (74 . 8) 1 .95 (0.8 1 -4 .68) 0.050 
8 Reference group. 
b Excluded category from OR calculations. 
C Only included are those with a history of international travel .  
d column percentage. 
e row percentage. 
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Using pnmary chool students as a reference group, intennediate school, 
secondary school and university students had significant odds ratios of 6.60 ( 1 .990-
2 1 . 872), p < 0.0 1 ; 5 .25 ( 1 .6 1 9- 1 7 .008) P < 0.0 1 ;  and 9. 1 1  (2.903-28.6 1 3) p < 0.0 1 ,  
respectively. The relationship between subject education and anti HA V antibodies is 
pre ented in Figure 1 5  where 58% of the primary school students were sero-negative 
compared to a range of 1 0-20.8% for the other groups. The difference between primary 
school students and i l l iterate subjects was remarkable, but statistical ly not significant p > 
0.0 1 probably because of the small number of i l literate subjects. 
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Figure 1 5 :  Distribution of UAE nationals according to education and anti HA V antibodies. 
Using al l students as a reference for odd ratio analysis, the group of employees and 
the group comprising both housewives and jobless subjects had odds ratios of 1 1 .25 
(2.634-48 .047), P < 0.0 1 and 8 .00 (2.973-2 1 . 530) p < 0.0 1 ,  respectively. The relationship 
between employment and anti HA V antibodies is presented in Figure 1 6, students
 were 
almost split equal ly between those with and without anti HA V antibodies, in mark c
ontrast 
to either the employees group or the group of housewives and jobless subjects (Figu
re 1 6). 
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Figure 1 6 :  Distribution of UAE nationals according to occupation and anti HA V 
antibodies. 
Multiple logistic regression was used to test which variable (s) among age, gender, 
education and occupation was (were) independently associated with anti HA V antibodies. 
Only age was found to be independently associated; using children 0-9 years of age as a 
reference group the adjusted OR (99% Cl) of 1 0- 1 9  years of age group was 4.06 ( l .0 1 7-
1 6.206), p < 0.0 1 and of 20-39 years age group was 38 .23 (09.364- 1 56 .079), p < 0 .01  as 
presented in Table 5 .  
Table 5 :  Adjusted odds ratios (OR) and 99 confidence intervals (Cl) for HA V antibodies 
in different age categories. 
Parameter OR (99% Cf) b P 
Age 
0-9 I '  
1 0 - 1 9  4.06 ( 1 .0 1 - 1 6. 2 1 )  0.009 
20-39 38.23 (9.36- 1 56.08) 0.000 
• Reference group 
b OR adjusted for gender, subject education and occupation. 
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1 1 1.3. Expatriates 
I I I .3. 1 .  ample characteristic 
A total of 333  expatriates comprised the subjects of th is study. Based on our assumption of 
h igh prevalence of HA V within th is heterogeneous group, we assumed that the overa l l  prevalence 
i about 90%. Consequently, using the same formula for calculating the required sample size as we 
d id  for UAE nationals; the minimum required number of subjects with 1 0% margin of error was 
60. The above number of subjects with 99% confidence level wi l l  give a margin of error of 4 .23%. 
I I I .3.2.  Questionnaire data and HA V serology 
The age range was (0-39) the same for UAE nationals and the mean ± standard deviation 
was 2 1 . 1 3  ± 1 0.9 1 2  years. The distribution of the expatriate subjects according to age was 
presented in Figure 1 7 . The number of subjects (23) in the age group 5-9 years was smal l (6.9 1 % of 
the total). 
20 0% 
Figu re 1 7 : Distribution of expatriate subjects in age groups of 5 years. 
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Therefore, subsequent analysis was done by grouping expatriates into 3 age groups; 
in the same way a we did for UAE nationals. The frequency of demographic parameters, 
their distributions according to hepatitis A exposure and as potential risk factors are 
presented in Table 6. 
The same trend of gender distribution as for UAE nationals was observed among 
expatriates i .e .  Females constituted most of the subjects as the samples were obtained from 
outpatients of Oad al Toaba and Khabisi cli nics and most of the attendees were females 
and chi ldren. Subject education and occupation was categorized into 6 and 3 groups, 
respectively in the same way as for UAE nationals, for both variables the category of 
preschool children was excluded from odd ratios calculations (Table 6). 
The age distribution according to hepatitis A exposure was presented in Figure 1 8 ; 
children in the first decade of l ife have relatively lower prevalence (62 .9%) compared to 








HA V Serology 
Age Groups 
121 0-9 
fJ 1 0- 1 9  
Ell 20-39 
Figu re 1 8 :  Distribution of expatriate subjects according to age groups and anti HA V 
serology. 
5 1  
The other non ignificant associations in binary logistic regressions are only presented in 
Table 6. 
Table 6 :  Distribution of demographic parameters and crude OR for hepatitis A exposure 


























�a u ndice: 
No 
Yes 
�nternational T ravel :  
No 
Yes 
[r ime of T ravel c :  
<2 Years 
>2 Years 
a Reference group 
b Excluded variable 
Freq uency Seronegative 
n (%)d n (%)e 
62 ( 1 8.6) 23 (37. 1 )  
72 (2 1 .6) 1 6  (22.2) 
1 99 (59.8) 1 3  (6.5) 
93 (27.9) 22 (23 .7) 
240 (72 . 1 )  3 0  ( 1 2 .5) 
39 ( 1 1 .7) 1 3  (33 .3) 
56 ( 1 6 .8) 16 (28 .6) 
47 ( 1 4 . 1 )  7 ( 1 4.9) 
65 ( 1 9.5)  4 ( 6.2) 
79 (23 .7) 8 ( 1 0 . 1 )  
47 ( 1 4 . 1 )  4 (08.5) 
86 (29 .3) 26 (30.2) 
65 (22 . 1 )  6 ( 9.2) 
1 43 (48 .6) 7 ( 4.9) 
53 ( 1 5 .9) 6 ( 1 1 .3 )  
1 48 (44.4) 30 (20 .3) 
1 32 (39 .6) 1 6  ( 1 2. 1 )  
324 (97 .3) 5 1  ( 1 5 .7) 
9 (02.7) 1 ( 1 1 . 1 )  
1 3 6  (40.8) 30 (22 . 1 )  
1 97 (59.2) 22 ( 1 1 .2) 
84 (42 .6) 1 3  ( 1 5 .5) 
1 1 3 (57 .4) 9 ( 8.0) 
Seropositive 
n (%)e 
39 (62 .9) 
56 (77 .8) 
1 86 (93 .5) 
71 (76.3) 
2 1 0 (87.5) 
26 (66.7) 
40 (7 1 .4) 
40 (85 . 1 )  
6 1  (93 .8) 
7 1  (89.9) 
43 (9 1 .5) 
60 (69. 8) 
59 (90 .8) 
1 36 (95 . 1 )  
47 (88.7) 
1 1 8 (79.7) 
1 1 6 (87.9) 
273 (84 .3) 
8 (88 .9) 
1 06 (77.9) 
1 75 (88 .8) 
7 1  (84.5) 
1 04 (92 .0) 
C Only included are those with a history of international travel. 
d column percentage. 
e row percentage. 
OR (99% CI) P 
I "  
2.06 (0.76-5 .59) 0.06 1 
8 .44 (3 . 1 0-22 . 1 0) <0.001 
1 a 
2. 1 7  (0.97-4 .85) 0.0 1 3  
1 " 
2.27 (0.62-8 .40) 0. 1 02 
6. 1 0  0 .32-28 .24) <0.003 
3 .55  ( 1 .04- 1 2. 1 0) <0.009 
4.30 (0.92-20.20) 0.Q l 5  
1 " 
4.26 ( 1 .2 1 0- 1 5 .00 1 )  <0.004 
8 .42 (2.62-27.05) <0.00 1 
1 • 
0.50 (0. 1 5 - 1 .73) 0. 1 5 1  
0.93 (0.25-3 .43) 0.879 
1 a 
1 .50 (0. 1 0-23.62) 0.708 
1 a 
2.25 ( 1 .022-4.96) <0.009 
1 • 
2. 1 2  (0.65-6.92) 0 . 1 03 
28. 6% of primary school children had no anti HA V antibodies compared to a sero-
negative range between 6.2- 1 4 .9% for the other education categories (Figure 1 9) .  The 
difference between primary school chi ldren and i l l iterate subjects was remarkable, but 

















Figure 1 9 :  Distribution of expatriate subjects according to education and anti HA V 
antibodies. 
The group of employees and the group comprising housewives and unemployed 
subjects had significant odds ratios of 4.26 ( 1 .2 1 0- 1 5 .00 1 ), p < 0.0 1 and 8 .42 (2.620-
27.05 1 ), p < 0.0 1 ,  respectively when students were used as a reference group. The percent 
of hepatitis A sero-negative in students was 3 and 6 times higher than in employees or in 
the group comprising housewives or jobless expatriates, respectively (Figure 20). 
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Figure 20: Distribution of expatriate subjects according to occupation and anti HA V 
serology. 
Expatriates with a history of international travel had higher risk for hepatitis A 
compared to those with no such history OR = 2.25 ( 1 .022-4.958), p < 0 .0 1  (Table 6). The 
percent of hepatitis A sero-negative expatriates was almost double in those with no history 
of international travel compared to expatriates with such history (Figure 2 1 ). 
1 00.0% 
80 0% 










Figure 2 1 : Distribution of expatriate subjects according to history of international travel 
and anti HA V serology. 
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Multiple logistic regreSSIOn was used to test which variable (s) among age, 
education, occupation and international travel is (are) independently associated with 
hepatitis A exposure. Only occupation was independently associated with hepatitis A 
antibodies: The [OR (99% C I), p value] of hepatitis A antibodies for employee (students as 
reference group) was [4 .26 ( 1 .2 1 0- 1 5 .00 1 ), P < 0.0 1 ] , while for house-wife or unemployed 
was [ 8 .42 (2 .620-27 .05 1 ), p < 0.0 1 ]  as shown in Table 7.  
Table 7:  Adjusted OR and 99 confidence interval for HA V exposure antibodies ill 





House-wife or unemployed 
OR (99% cnb 
1 a 
4.26 ( 1 .2 1 - 1 5 .00) 




• Reference group 
b OR adjusted for age, subject education and history of international travel .  
m.4. UAE nationals and Expatriates inhabiting Al  Ain :  differences In 
demographic and serological parameters 
I II .4. I .  Differences between UAE nationals and expatriates in aU age groups 
In this section the two populations were tested for difference in proportions in 
demographic and serological parameters in order to try to relate the observed differences in 
the endemicity of hepatitis A between UAE nationals and expatriates to differences in one 
or more of the demographic parameters (Table 8). 
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Table 8 :  Distribution of demographic parameters and hepatitis A exposure in UAE 
nationals (n = 280) and expatriates (n = 333) inhabitants of Al Ain city: 
Parameter 
UAE National Expatriate 2 
N (%) n (%) X P 
Age group 
0-9 71 (25.4) 62 ( 1 8.6) 
1 0· 1 9  54 ( 1 9.3) 72 (2 1 .6) 2 .84 0.092 
20·39 1 55 (55.4) 1 99 (59.8) 
Gender 
Male 63 (22.5) 93 (27.9) 2.09 0. 1 49 
Female 2 1 7  (77.5) 240 (72 . 1 )  
Subject Education • 
Primary 50 (2 1 .2) 56 ( \ 9.0) 
l ntennediate 52 (22.0) 47 ( 1 6.0) 
Secondary 48 (20.3) 65 (22. 1 )  6.23 0.0 1 3  
University 76 (32.2) 79 (26.9) 
I l l iterate 1 0  ( 4.2) 47 ( \ 6.0) 
Total 236 ( 1 00) 294 ( 1 00) 
Occupation • 
Student 88 (37.3)  86 (29.3)  
Employee 49 (20.8) 65 (22. 1 )  3 .97 0. 1 37 
Housewife or jobless 99 (4 1 .9) 1 43 (48.6) 
Total 236 ( 1 00) 294 ( 1 00) 
Crowding Category 
Low 50 ( J  7.9) 53 ( 1 5 .9) 
Medium 1 66 (59.3) 1 48 (44.4) 1 1 .46 <0.002 
H igh 64 (22.9) 1 32 (39.6) 
Jaundice 
No 266 (95.0) 324 (97.3) 1 .63 0.20 1 
Yes 1 4  ( 5.0) 9 ( 2 .7) 
I nternational  Travel 
No 1 1 0 (39.3) 1 36 (40.8) 0. 1 0  0.758 
Yes 1 70 (60.7) 1 97 (59.2) 
Destination of Travel b 
Africa 3 ( 1 .8) 2 ( 1 .0) 
America 7 (4. 1 )  1 (0.5) 
South East Asia 1 9  ( 1 1 .2) 64 (32.5) 
Europe 1 7 (0 1 0) 8 ( 4 . 1 )  3 1 .9 1  <0.001 
East Mediterranean 1 22 (7 1 .8) 1 1 7 (59.4) 
West Pacific 2 ( 1 .2) 5 ( 2 .5)  
Total 
Time of Travel b 
1 70 ( 1 00) 1 97 ( 1 00) 
<2 years 63 (37. 1 )  84 (42.6) 
>2 years 1 07 (62.9) 1 1 3 (57.4) 0.96 0.327 
Total 1 70 ( 1 00) 1 97 ( 1 00) 
HA V Serology 
Negative 97 (34.6) 52 ( 1 5 .6) 28.9 1 <0.001 
Positive 1 83 (65.4) 28 1 (84.4) 
a preschool children were excluded. 
b Subjects with no history of international travel were excluded. 
The two groups were compared for age, gender, education, occupation, crowding 
category, history of jaundice, "history, destination and time of international travel ", and 
exposure to hepatitis A as measured by anti HA V antibodies. Statistical ly significant 
differences were found between the two groups in crowding category l = 1 1 .46, p < 0.0 1 ,  
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de tination of tra el l = 3 1 .9 1 ,  P < 0.0 1 and exposure to hepatitis A l = 28 .9 1  p < 0 .0 1  as 
hown in Table 8 .  For education the difference between the two groups was remarkable but 
statistical l insignificant l = 6.23,  p = 0.0 1 3 . 0 statistical ly significant difference was 
found between the two groups with regard to age or gender. 
In education the main difference was between the i l l iterate; 1 6% in expatriates 
















Figure 2 2 :  Distribution of U AE nationals and expatriates according to education level . 
More expatriates (39.6%) than UAE nationals (22.9%) were classified in the high 
crowding category. Whereas, more UAE nationals were in the medium crowding category 
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Figu re 23 : Distribution of UAE nationals and expatriates according to crowding category. 
Both groups traveled substantial ly to East Mediterranean countries (Saudi Arabia is 
included in this region) , but the UAE nationals traveled more to Europe and America, 
whereas the expatriates traveled more to South East Asia as i l lustrated in Figure 24. 
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Figu re 24 :  Distribution of UAE nationals and expatriates according to destination of latest 
travel . 
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The prevalence of hepatitis A in UAB nationals was 65 .4% compared to a 
prevalence of 84.4% among the expatriate group (Figure 25).  
-c: Q) 













Figu re 25:  Distribution of UAE nationals and expatriates according to hepatitis A 
exposure as measured by anti HA V antibodies. 
The age related difference in hepatitis A seroprevalence between UAB nationals 
and expatriates was evident and a steep versus moderate fal l  in seroprevalence was 
observed in children and adolescents compared to adults in UAB nationals and expatriates, 
respectively (Figure 26). 
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Figure 26:  Age related difference in the seroprevalence of hepatitis A in UAB nationals 
and expatriates. 
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I I I .4.2. Differences between UAE nationals and expatriate children in their first 
decade of l ife (0-9 years of age) 
The only significant difference was in hepatitis A exposure between the two groups 
ex 2 = 27 .7 1 ,  p < 0.0 1 ) . The seroprevalence were 1 6 .9% in UAE national chi ldren in 
contrast to 62.9% expatriate chi ldren, indicating a differential exposure to hepatitis A in 
the two groups (Table 9). 
Table 9: Distribution of demographic parameters and hepatitis A exposure in UAE 
nationals and expatriates inhabitants of Al Ain city in their first decade of l ife : 
UAE 
Expatriate 
Para meter Nationals t p 
n (%) n (%) 
Gender 
Male 39 (54.9) 35 (56.5) 
Female 32 (45. 1 )  2 7  (43 .5)  0.000 0.999 
Total 7 1  ( 1 00) 62 ( 1 00) 
Crowding Category 
Low 1 3  ( 1 8 .3) 7 ( 1 1 .3 )  
Medium 38 (53.5)  27 (43.5) 4.06 0.044 
H igh 20 (28.2) 28 (45.2) 
Total 7 1  ( 1 00) 62 ( 1 00) 
Jaund ice 
No 66 (93.0) 60 (96.8) 
Yes 5 ( 7.0) 2 ( 3 .2) 0.35 0.552 
Total 7 1  ( 1 00) 62 ( 1 00) 
I n ternationa l  Travel 
No 43 (60.6) 46 (74.2) 
Yes 28 (39.4) 16 (25.8) 2.20 0. 1 3 8  
Total 7 1  ( 1 00) 62 ( 1 00) 
Destination of Travel ' 
Africa 0 (00.0) 1 ( 6.3) 
South-East Asia 3 ( 1 0.7) 2 ( 1 2.5) 1 .94 0.585 
Europe 3 ( 1 0.7) 2 ( 1 2.5 )  
East Mediterranean 22 (78.6) I I  (68.8) 
Total 28 ( 1 00) 1 6  ( 1 00) 
Time of Travel • 
<2 years \ 6 (57. 1 )  \ 2  (75.0) 
>2 years 1 2 (42.9) 4 (25 .0) 0.74 0.390 
Total 28 ( 1 00) 1 6 ( 1 00) 
HA V Serology 
Negative 59 (83. 1 )  23 (37. 1 )  
Positive 1 2 ( 1 6.9) 39 (62.9) 27.7 1 <0.001 
Total 7 1  (100) 62 (\ 00) 
• only included are those with a history of international travel .  
I T I .4.3. Differences between UAE nationals and expatriates in their second decade of 
l ife ( 1 0- 1 9  years of age) 
Again a significant difference was found in hepatitis A exposure between the two 
groups ex 2 = 7 .00, p < 0.0 1 ). The prevalence of hepatitis A in this age group was 53 .7% 
60 
and 77 .8  in UAE nationals and expatriates, respectively (Table 1 0). Another significant 
difference between the two groups was in the destination of the latest travel (x 2= 1 8 .56 P < 
0.0 1 ). The difference was remarkable with regard to travel to Europe and South East Asia 
for UAE nationals and expatriates, re pectively (Table 1 0). 
Table 1 0 : Distribution of demographic parameters and hepatit is A exposure in UAE nationals and 
expatriates inhabitants of AI Ain city in their  second decade of l i fe :  
Para meter 
UAE National E.x patriate l n (%) n (%) p 
Gender 
Male 14 (25.9) 27 (37.5) 
Female 40 (74. 1 )  45 (62.5) 1 . 39 0.238 
Total 54 ( 1 00) n ( 1 00) 
Subject Education 
Primary 1 2  (22.2) 20 (27.8) 
lntennediate 24 (44.4) 28 (38.9) 
Secondary 1 6  (29.6) 1 3 ( 1 8. 1 )  0.69 0.4 1 
University 1 ( 1 .9) 2 (02.8) 
I l l iterate 1 ( 1 .9) 9 ( 1 2.5) 
Total 54 ( 1 00) n ( 1 00) 
Occupation 
Student 39 (72.2) 58 (80.6) 
Employee 3 ( 5 .6) 2 ( 2.8) 1 .38 0.502 
House-Wife or 1 2  (22.2) 12 ( 1 6.7) 
Unemployed 
Total 54 ( 1 00) n ( 1 00) 
Crowding Category 
Low 4 ( 7.4) 3 ( 4.2) 
Medium 33 (6 1 . 1 )  3 3  (45.8) 4.23 0.04 
H igh 1 7  (3 1 .5) 36 (50.0) 
Total 54 ( \ 00) n ( 1 00) 
Jaund ice 
No 53 (98. 1 )  69 (95.8) 
Yes 1 ( 1 .9) 3 ( 4.2) 0.05 0.826 
Total 54 ( 1 00) n ( 1 00) 
I nternational Travel 
No 1 9  (35.2) 35  (48.6) 
Yes 35 (64.8) 37 (5 1 .4) 1 . 756 0. 1 85 
Total 54 ( 1 00) n ( 1 00) 
Destination of Travel' 
America 1 ( 2.9) 00 (0.00) 
South-East Asia 1 ( 2 .9) 1 3 (35. 1 )  
Europe 6 ( 1 7. 1 )  00 (0.00) 1 8.56 <0.002 
Eastem- 27 (77. \ )  23 (62.2) 
Mediterranean 
Western-Pacific 00 (0.00) I ( 2.7) 
Total 35 ( 1 00) 37 ( 1 00) 
Time of Travel' 
<2 years 1 3  (37. 1 )  2 1  (56.8) 
>2 years 22 (62.9) 1 6 (43.2) 2.05 0. 1 53 
Total 35 ( 1 00.0) 37 ( 1 00.0) 
HA V Serology 
1 6  (22.2) Negative 25 (46.3) 
Positive 29 (53.7) 56 (77.8) 7.00 <0.009 
Total 54 (100) n (100) 
• only included are those with a history of international travel .  
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1 1 1 .4.4. Difference between UAE nationals and expatriates adults (20-39 yea rs of 
age): 
The differences in distribution of many demographic parameters between UAE 
nationals and expatiates adults (20-39 years old) were statistical ly significant in: 
occupation (x 2= 1 7 .03 , p < 0 .0 1 )  and destination of the latest international travel (x 2= 
1 9 . 1 9, p < 0.0 1 ) . 
The main difference in occupation was in the percent of jobless and housewives 
was higher in expatriates (65 . 8%) than in UAE nationals (56.8%), whereas the percent of 
UAE nationals' students was 5 times greater than that of the expatriate students (Table 1 1 ) .  
The destination of latest international travel showed more or less the same trend in the two 
groups as described above for the 1 0- 1 9  years of age. 
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Table 1 1 : Distribution of demographic parameters and hepatitis A exposure in UAE 
nationals and expatriates adults (20-39 years of age) inhabitants of Al Ain: 
UAE 
Expatriate Parameter National 2 
n (%) X P 
n (%) 
Gender 
Male 10  ( 6.5) 3 1  ( 1 5.6) 
Female 1 45 (93 .5) 1 68 (84.4) 6.22 0.0 1 3  
Total 1 55 ( 1 00) 1 99( I 00) 
Subj ect Ed ucation 
Primary I I  (07. 1 )  1 3  ( 6.5)  
Intermediate 28 ( 1 8. 1 )  1 9  ( 9.5) 
Secondary 32 (20.6) 52 (26. 1 )  5 . 1 7  0.023 
University 75 (48.4) 77 (38.7) 
I l l iterate 9 ( 5 .8) 38 ( 1 9. 1 )  
Total 1 55 ( 1 00) 1 99 ( 1 00) 
Occu pation 
Student 22 ( 1 4.2) 5 ( 2.5) 
Employee 46 (29.7) 63 (3 1 .7) 1 7.03 <0.001 
Housewife or jobless 87 (56. 1 )  1 3 1  (65 .8) 
Total 1 55 ( 1 00) 1 99 ( 1 00) 
C rowd ing Category 
Low 33 (2 1 .3)  43 ( 2 1 .6) 
Medium 95 (6 1 .3)  88 (44.2) 4.89 0.027 
H igh 27 ( 1 7.4) 68 (34.2) 
Total 1 5 5 ( 1 00) 1 99 ( 1 00) 
Jaund ice 
No 1 47 (94 .8) 1 95 (98.0) 
Yes 8 ( 5 .2) 4 ( 2.0) 1 . 77 0. 1 84 
Total 1 55 ( 1 00) 1 99 ( l 00) 
International Travel 
No 48 (3 1 .0) 55 (27.6) 
Yes 1 07 (69.0) 1 44 (72.4) 0.32 0.571  
Total 1 55 ( 1 00) 1 99( 1 00) 
HA V Serology 
Negative 0 1 3  (08.4) 0 1 3  (06.5) 
Positive 1 42 (9 1 .6) 1 86 (93 .5)  0 .2 1  0.647 
Total 1 55 ( 1 00.0) 1 99 ( 1 00.0) 
Destination of Travel a 
Africa 3 ( 2.8) I ( 0.7) 
America 6 ( 5.6) I ( 0.7) 
South-East Asia 1 5 ( 1 4.0) 49 (34.0) 
Europe 8 ( 7.5) 6 ( 4.2) 1 9. 1 9  <0.003 
Eastem-
73 (68.2) 83 (57.6) 
Mediterranean 
Westem-Pacific 2 ( 1 .9) 4 ( 2.8) 
Total 1 07 ( 1 00) 1 44 ( 1 00) 
Time of Travel a 
<2 years 34 (3 1 .8) 5 1 (35 .4) 
>2 years 73 (68.2) 93 (64.6) 0.22 0.640 
Total 1 07 ( 1 00) 1 44 ( 1 00) 




UAE is a leading country in the Middle East in terms of outstanding, swift and 
sustainable progress in all aspects of l ife including hygiene and sanitation. Such progress 
has started about 3 decades ago and never faded since, on the contrary is gaining 
momentum. Therefore, we expected that as time passes by the overall prevalence of 
hepatitis A wi l l  fal l  due to a plausible interpretation that better standards of l iving results in  
less exposure to the virus and hence chi ldren and adolescents wil l  have less prevalence 
compared to adults. This is because adult UAE nationals l ived their childhood in less 
hygienic environment and were exposed to the virus and remained sero-positive since then. 
Such fal l  in prevalence of hepatitis A is expected to be seen all over the country provided 
that ethnic composition of UAE society is taken in consideration i .e . ,  what may apply for 
UAE nationals may not apply to the same extent to the bulk of expatriate population. The 
latter group constitutes 78 . 1 % of total UAE population (2005 UAE population census), is 
highly heterogeneous ethnically and socio-economically, unstable and comprises basically 
of citizens of countries highly endemic for hepatitis A. On the other hand UAE nationals 
are more homogenous ethnical ly (predominantly Arabs) and general ly have higher 
socioeconomic status compared to expatriates. Results of this study revealed important 
differences in seroprevalence of hepatitis A and underlying risk factors between UAE 
nationals and expatriates. 
To our knowledge this is the fIrst seroprevalence study on hepatitis A in UAE that 
covered a wide range of age including children, adolescent and adults in contrast to two 
previous studies done in Abu Dhabi. The fust was conducted by. sampling 1 009 army 
volunteers; the reported prevalence was 93 .5% (Albloushi et aI, 1 995a) .  The study 
indicated that hepatitis A was highly prevalent in UAE army at that time. However, 
paradoxical ly in another study conducted by the same researchers (Albloushi et al, 1 995b); 
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the 0 eraIl prevalence was 77 . 5% among 1 583 adults from mixed mil itary and civil ian 
population ( 1 1 57 men and 426 women), such seroprevalence is more in agreement with an 
intermediate pattern of endemicity. The researchers predicted that prevalence of HA V wil l  
decrease in  the future because of  obvious improvement of  living standards and sanitation 
in UAE (Albloushi et al, 1 995b). In Alblousru and co-investigators studies, the subjects 
were not wel l  characterized with regard to the ethnic composition but it is logical to 
assume that they were mixed adult population of UAE nationals and expatriates. In our 
study the overal l seroprevalence of hepatitis A were 65.43% and 84.38% among UAE 
nationals and expatriates, respectively. However, it is not useful to compare these 
prevalence with those reported by Alblousru and co-investigators because of the difference 
in age of subjects between our study and the two above mentioned studies. 
One of the limitations of this study is the fact that it is a hospital based one, 
however every effort was taken to avoid inclusion of outpatients referred from the 
gastrointestinal cl inic, moreover, as the serological test measures predominately past 
exposure it is not expected the seroprevalence of hepatitis A in outpatients wil l  differ from 
the proportion in the general population. Also, the time limitations and the need to 
condense the questionnaire form imposes that details on occupation were not included 
(rather all employee were grouped as one entity), furthermore, other parameters that reflect 
the socioeconomic status e.g. type of housing and income were not included. 
In this study, the difference in seroprevalence of hepatitis A in children, adolescents 
and adults is a reflection to what is expected from improvement in standards of l iving in 
UAE during the last 2-3 decades. It is wel l  documented that in countries witnessing 
remarkable development with improvement in the standard of l iving, lower seroprevalence 
of HA V are expected in chi ldren and adolescents compared to adults (Jakobsen and 
Koopman, 2004). Such age related fal l  in exposure to hepatitis A may give a warning 
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signal that as time passes a buildup of a growing pool of susceptible adolescents and 
young adults will take place in the foreseeable future. The severity of hepatitis A disease 
increases with age of onset leading to substantial increase in morbidity and mortality 
(Jakobsen and Koopman 2005; Almuneef et al, 2006), therefore, consideration to 
introduce HA V vaccination into the national immunization schedule in UAE should not be 
overlooked. Our study provides evidence that AI Ain city should be classified as an area of 
intermediate endemicity and that exposure to hepatitis A is falling in children and 
adolescents compared to adults. This study points to the need for nationwide 
epidemiological studies in order to assess current and future of hepatitis A prevalence in 
UAE and the likely need to implement a vaccination program in the near future. 
The seroprevalence pattern of HA V found in this study among UAE nationals of AI 
Ain city is similar to the age related fall in seroprevalence described in many other 
countries in the Middle East experiencing improvement in standards of living e.g., Saudi 
Arabia (Tufenkeji, 2000), Lebanon (Sacy et ai, 2005) and Tunisia (Letaief et al, 2005). In 
Saudi Arabia, there was a significant fall in hepatitis A seroprevalence in children up to 1 2  
years old throughout the country, except in an area bordering Yemen. Another study 
involved 490 Saudi children in Riyadh reported that by the age of 1 1  years, only 45% were 
sero-positive indicating an intermediate endemicity in Riyadh city. The highest 
seroprevalence was reported in children from rural backgrounds, whereas lower 
seroprevalence were reported in Bedouin and urban children. Furthermore, hepatitis A 
exposure was highly associated with socioeconomic status of the child (Tufenkeji, 2000). 
In Lebanon a gradual fall in seroprevalence of hepatitis A was reported among 606 
subjects (age 1 -30  years). Comparable to our findings, age was the most important 
significant factor associated with HA V exposure, in adults > = 2 1  years HA V 
seroprevalence was 78%, dropped to 28% in children 6- 1 0  years and 1 1  % in those 1 -5 
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year ( acy et aI, 2005). In Tunisia 2,400 subjects with an age range of 5-20 years were 
tested for HA V - IgG, the overal l seroprevalence was 60% which is comparable to the one 
for UAB nationals in our study. The seroprevalence fal l  was from 83% in subjects > 1 5  
years to 5 8% in chi ldren 1 0- 1 5  years and 44% in chi ldren < 1 0  years (Letaief et al , 2005). 
Our findings of an age related fal l  in the seroprevalence of hepatitis A in UAB 
nationals in Al Ain city is in contrast to similar studies from Egypt, Syria, Palestine and 
the Iraqi-Turkey borders. The overal l seroprevalence of anti-HA V antibodies was 86.2% in 
426 Egyptian chi ldren age 3- 1 8  years and the age related fal l  was much slower compared 
to our study; 90% in  > 1 1  years, 85 .3% in 6- 1 0  years and dropped to only 64.3% in 
children < 6 years. In Egypt previous studies reported overal l seroprevalence of 89.4% in 
Alexandria and 1 00% in rural areas (Salama et ai, 2004). In Syria and Palestine, also high 
prevalence were reported, 89% and 93 .3%, respectively (Salama et aI, 2004). The reported 
seroprevalence in the border between Iraq and Turkey was 94.4% (Almuneef et al , 2006) . 
Considering the time l imitation of this study and that most of the out-patients were 
females and chi ldren, we were unable to avoid an imbalance in the sex ratio ( 1  :3 .44) of 
UAB national males and females, respectively. Furthennore, our fmdings, that males had 
significantly lower sero-positive (3 1 . 7%) compared to females (75 . 1 %) may not reflect a 
true gender difference as most of the males (6 1 .9%) were children < 1 0  years in contrast to 
only 1 4 .7% of females. The above interpretation is supported by the multivariable 
regression analysis revealing age as the only independent variable associated with 
exposure to hepatitis A. Furthennore, no statistical ly significant difference was found 
between UAE national males and females in any age group in hepatitis A exposure (data 
not shown). In support to the above interpretation many studies reported no gender 
difference in seroprevalence of hepatitis A e.g. ,  almost equal prevalence in males (28.2%) 
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and females (29.5%) among 2399 audi chi ldren 4- 1 8  years of age (Almuneef at el, 2006) . 
In Egypt the seroprevalence in males was 85 .3% and in females was 86.9% among 426 
Egyptian children 3 - 1 8  years ( alama et al 2004). In Lebanon 740 children 0.5- 1 5  years 
old were tested for HA V antiboclies (IgO), the male to female ratio was 1 . 8 :  1 and no 
significant difference in seroprevalence between males (3 1 . 3%) and females (25 .7%) 
(Kalaajieh et al, 2000). 
Subject education and occupation were also found significantly associated with hepatitis A 
exposure in UAE nationals in this study. The seroprevalence was 42% in subjects with 
primary education compared to 86.8% in subjects with university education and 90% in 
illiterate subjects. However, as for gender, age could explain the above difference in the 
seroprevalence of hepatitis A as 54% of subjects with primary education were children 
(data not shown). In contrast to our multi variable regression analysis fmdings in Lebanon, 
the same analysis revealed that seroprevalence were significantly higher in 
subjects/parents/guardians with pnmary education compared with 
subjects/parents/guardians with university education (Sacy et al, 2005). The binary logistic 
regression indicates that a housewife or unemployed had 8 times odds of being exposed to 
hepatitis A, compared to a student and an employee who had 1 1  times odds of being 
exposed compared with a student, however, again the effect of age should not be ignored 
as 75% of students were children and adolescents (data not shown). 
After control l ing, for confounding factors by using multiple regression tests, only 
age was found significantly associated with hepatitis A exposure in UAE nationals. An 
U AE national adult or a subj ect in the age range 1 0- 1 9  years had 3 8  and 4 times the odds 
of being exposed to hepatitis A compared with a child < 1 0  years of age, respectively. 
This provides strong evidence that there is an age-related fal l  in prevalence of hepatitis A 
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I n  in city among UAE nationals and the overal l prevalence is in accordance with areas 
having intermediate endemicity .  
In expatriates the overall seroprevalence (84.38%) and the rather gradual age­
related fal l  in the seroprevalence of hepatitis A (range 62.9-93 .5%) are in contrast with 
U E nationals or the pattern of age-dependent shift in the seroprevalence reported from 
countries witnessing remarkable progress. The pattern in expatriates in agreement with 
reported age-related marginal changes in the epidemiology of hepatitis A in developing 
countries, taking India for example as a developing country where most of the population 
is infected in early childhood. The overal l seroprevalence of hepatitis A reported among 
the general population from different parts of India ranges between 85% and 98% and 
therefore the country as a whole is regarded as highly endemic (Hussain et al, 2006). It is 
worth mentioning that the majority of the expatriate population l iving in UAE is from the 
Indian sub-continent and other developing countries of the world and therefore it is not 
surprising to find the above pattern among our expatriate subjects. 
The same trend of gender distribution as for UAE nationals was observed among 
expatriates i .e .  Females constituted 72. 1 % of the subjects as the samples were obtained 
from outpatients of Oad al Toaba and Khabisi clinic and most of the attendees were 
females and children. However, unlike for UAE nationals the difference in the 
seroprevalence between males (76.3%) and females (87.5%) was statistically insignificant 
supporting that age-related fal l  in seroprevalence was gradual in expatriates. Furthermore, 
no statistical ly significant difference was found between expatriate males and females in 
any age group in hepatitis A exposure (data not shown). 
In expatriates, history of international travel associated with exposure to hepatitis 
A, this may be interpreted as many expatriates get the infection when they visit their home 
countries. However, the association was not supported by the results of multivariable 
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l ogistic regression presenting occupation as the only independent variable associated with 
hepatitis A exposure. 
ubject education and occupation were also found significantly associated with 
hepatiti A exposure in expatriates. The seroprevalence was 7 1 .4% in subjects with 
primary education compared to about 90% prevalence in subjects with university education 
or i l l iterate subjects. However, in contrast to UAE national subjects' age probably was not 
responsible for the above difference in the seroprevalence of hepatitis A as 54% of subjects 
with primary education were in the 1 0- 1 9  age group (data not shown). Both binary and 
multivariable logistic regressions indicate that a housewife or an unemployed subject had 
8.4 times odds of being exposed to hepatitis A compared to a student and an employee who 
had 4.2 times odds of being exposed. However, again the effect of age was probably minor 
as 67.4% of students were 1 0- 1 9  years of age whereas >90% of the two other groups were 
adults (data not shown) an interpretation supported by multi variable regression analysis 
fmdings that occupation was the only independent variable associated with exposure to 
hepatitis in expatriates. 
X2 test was employed to test if seroprevalence or any of the demographic 
parameters was different between UAE nationals and expatriates. Statistically significant 
differences were found between the two groups in crowding category, destination of travel 
and exposure to hepatitis A, furthermore the difference in education was remarkable. No 
stati stical ly significant difference was found between the two groups in age or gender 
indicating that above mentioned differences between the two groups could not be attributed 
to age or gender. labors 
In expatriates, the i l l iterate proportion was higher than in UAE nationals, this can 
be due to the fact that al l farmers, onsite construction workers, unskil led laborers . . .  etc. ,  
7 1  
are exclusi ely expatriates and many of them are low ill socioeconomic status and 
i 1 1 i  terate . 
The crowding category, as a measure of the socioeconomic status revealed that 
higher percentage of expatriates can be classified as people l iving in high crowding 
condition compared with UAE nationals.  This can also be explained that low income 
laborers l ive in smal l homes in order to save money. It is worth mentioning that many 
UAE nationals have large famil ies but do not live in crowding condition because of their 
high income and large homes. Large family size and crowding are associated with 
increased risk of infection with hepatitis A (Jacobsen and Koopman, 2004). 
Both UAB nationals and expatriates traveled frequently to the East Mediterranean 
than any other region of the world this is due to visits to Saudi Arabia for Hajj and Omra. 
UAE nationals traveled more to Europe and America, whereas the expatriates traveled 
more to South East Asia. The fust could be mainly for tourism, study or treatment, whereas 
the latter mainly to visit their home countries. The difference in the destination of travel 
also reflects the difference in the socioeconomic status between the two populations. 
Comparing UAB nationals and expatriates in each age group for difference m 
seroprevalence and demographic parameters revealed that in chi ldren < 1 0 years only 
hepatitis A exposure was significantly different in the two groups. The results showed that 
few of UAB nationals' chi ldren were sero-positive ( 1 6 .9%) in contrast to expatriate 
chi ldren (62.9%) indicating a differential exposure to hepatitis in the two groups. This 
deference is most probably because of the differences in the l iving standards, UAE 
nationals chi ldren expected to be l iving within better standards and also because most of 
the expatriates subjects (including children) came mainly from East Mediterranean and 
South-East Asia countries which general ly have lower standards of l iving compared to 
UAE. 
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ignificant difference was found in hepatitis A exposure between UAE nationals 
and expatriates in their second decade of l ife ( 1 0- 1 9  years of age) and apparently for the 
arne reasons of the previous age group. The prevalence of hepatitis A in this age group 
as lower in UAE nationals (53 .7%) compared with the expatriates (77 .8%). Another 
significant difference between the two groups in above age group was in the destination of 
the latest international travel .  The difference was remarkable with regard to travel while all 
the subjects traveled to Europe and America were UAE nationals most of the subjects who 
traveled to the South East Asia were expatriates. The same difference in travel applies for 
adults of the two studied groups. 
The differences in distribution of many demographic parameters between UAE 
nationals and expatiates adults (20-39 years old) were statistically significant in destination 
of latest travel (explained above) and occupation, furthennore, the difference in education 
and crowding category was remarkable between adults of the two groups. All  the above 
differences could be attributed to the difference in the l iving standards between the two 
populations. 
The above differences are remarkable but the two populations should be taken into 
consideration with regard to evaluation of the endemicity of hepatitis A in Al Ain and in 
the country as a whole. The combined prevalence of UAE nationals and expatriates 
strongly support that Al All city is an area of intennediate endemicity and this probably 
holds true for most areas of UAE. However, further transition to low endemicity wil l  occur 
over a long period of time in UAE despite the remarkable progress because 78 .9% of the 
population is expatriates according to 2005 population census. Therefore, the health 
authorities in UAE should take the ethnic composition of the country in consideration in 
any future vaccination program in UAE. 
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In developed countries such as Canada (low endemic country) where hepatitis A 
accine is  currently recommended to individuals at risk, the seroprevalence in Canadian­
borne children was about 1 % in 8- 1 3  years, 1 -6% in 20-24 years, 1 0% in 25-29 years and 
1 7% in 30-39 years (Pham at el, 2005). In USA sera from 2 1 ,260 participants of 6 years 
old and above were collected in 1 988- 1 994 (before the commercial avai labil ity of hepatitis 
A vaccine in 1 995) and tested for hepatitis A antibodies. The overal l prevalence of HA V 
infection was 3 1 .3% and increased markedly with age. The prevalence of HA V was higher 
among both US- and foreign-born Mexican-Americans compared with non-Hispanics in al l 
age groups which indicated that ethnicity and low socioeconomic status associated with a 
higher prevalence of hepatitis A (Bell et ai, 2005). The targeted use of hepatitis A vaccine 
since 1 995 in USA led to a decrease of the number of cases infected with hepatitis A from 
32,000 reported cases in 1 990 to 7,700 in 2003 and most of the reduction happened in 
children (Brundage and Fitzpatrick, 2006). In USA the vaccination program targeting 
mainly high risk groups such as patients suffering from chronic l iver diseases, food 
handlers, sewage workers recipients of clotting factor concentrate and day-care centers 
(Arankalle and Chadha, 2003). Moreover, at risk groups include: international travelers 
going to high endemic areas, persons who work with hepatitis A virus l ike in research 
laboratory and i l l icit drug users (Bell, 2002). The overal l fatality due to hepatitis A in USA 
is relatively low about 0 .3%, however this  percent can increase up to 2% in adults older 
than 40 years (Brundage and Fitzpatrick, 2006). In October 2005 , the Advisory Committee 
on Immunization Practices (ACIP) in USA recommended universal hepatitis A vaccination 
which should be implemented into routine childhood immunization schedule at age 1 or 2 
years (Brundage and Fitzpatrick, 2006). 
Cost-benefit analysis revealed that targeted vaccination program is more 
economical than mass vaccination, especial ly in the areas with high hepatitis A prevalence 
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(Jacob en and koopman, 2004). However many countries were considering or have 
decided to start a mass vaccination against hepatitis A. This kind of immunization 
programs against hepatitis A have already been implemented in many countries including 
Spain, Italy and Israel .  For these countries, it seems logical to consider use of combined 
vaccines for hepatitis A and B and/or hepatitis A, B and E, implementing such procedure 
will  lead to many advantages such as lesser inj ections for protection against two infections, 
better compliance, lower implementation costs, and fewer missed vaccination opportunities 
(Damrne and Wielen, 200 1 ) . The effectiveness and cost-benefit analysis of such 
vaccination programs proved to be both medical ly and economically reasonable in these 
countries (Sacy el at, 2005). In Israel,  a 95% decrease in hepatitis A rates was observed 
after starting the routine hepatitis A vaccination program of chi ldren 1 8-24 months 
(Samuels, 2005;  Almuneef et al, 2006). 
If other prevalence studies support the fIDdings of our study and the age-dependent 
fal l  in hepatitis A proved true in UAE at large, then mass vaccination program targeting 
chi ldren and adolescents wil l  be inevitable together with introduction of hepatitis A 
vaccination in the routine chi ldhood vaccination program. Such mass vaccination program 
should be economical ly feasible and attainable in relatively short time because only about 
1 0% of the total population is UAB nationals, under 20 years of age i .e . ,  about 400,000 
persons (2005 UAB population census). It is expected that if the current trend of hepatitis 
A prevail s  in UAE without intervening control program the number of hepatitis A non 
immune UAB nationals wil l  flare-up in the nearby future with serious consequences in 
terms of i ncreased morbidity and mortality due to the virus. Therefore, this study provides 
evidence that the situation of hepatitis A should be monitored and studied carefully in 
UAE. Furthermore, such research should be communicated to the health authority in order 
to implement the research outcome into pol icies and programs benefiting the country. 
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v. CONCLUSION & RECOMMENDATIONS 
v. Concl usion and Recom mendations 
Worldwide the endemicity of hepatitis A can be categorized into three major 
patterns, namely low, intermediate and high depending on the extent and length of progress 
in living standards particularly hygiene and sanitation. This study provides the rust 
evidence that Al Ain, as a model city reflecting the remarkable progress in UAE, should be 
considered as an area of intermediate endemicity. Furthermore, it points to the need of 
considering the ethnic composition in perspective when analyzing the epidemiological data 
on hepatitis A as differential exposure to the virus was evident in UAE nationals and 
expatriates. The age-dependent fal l  in seroprevalence was steep in the former and gradual 
in the latter leading to a remarkable difference between children and adolescents but not 
the adults of the two populations. In the two populations adults had high seroprevalence 
and therefore immune, but only DAE national chi ldren and adolescents had low and 
intermediate seroprevalence, respectively. Therefore as time passes more adolescent and 
young adults UAE nationals will be borne to serious hepatitis A infections as it is wel l 
known that morbidity and mortal ity directly correlates with age. The availability of vaccine 
against hepatitis A makes preventive measures feasible and therefore one can recommend 
the fol lowing: 
• Nationwide epidemiological studies is required in order to assess current and 
future endemicity patterns of hepatitis A in UAE and the l ikely need to implement 
a vaccination program in the near future. 
• The result of the current study should be conveyed to the health authority for 
raising the awareness that in Al Ain, DAE nationals in their late chi ldhood and 
adolescents are susceptible to serious hepatitis A infections and preventive 
measures should be taken particularly during travel to high endemic countries. 
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• Future epidemiological studies should be done in col laboration with the Ministry 
of Health in order to promptly implement the research outcome into pol icies and 
programs. 
• If future studies revealed that the same pattern of prevalence as reported in this 
study is common to UAE, then mass vaccination targeting UAE national chi ldren 
up to 1 5  years of age and inclusion of hepatitis A in the routine chi ldhood 
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Questionnaire for the study entitled 
" Epidemiology of Hepatitis A in AI Ain :  with emphasis on age-related 
prevalence rate" 
Date of Birth :  Day /Month! Year 
Sex: Male D Female D 
Education : None 
Primary ( 1 -6 years) 
Intermediate (7-9 years) 
Secondary (9- 1 2  years) 
University 
Occupation: -------------------------------
No. of family members staying at home: D 
Number of bed rooms: D 
Previous History of Jaundice: Yes D 
History of international travel : Yes D 





Consent of the study entitled " Epidemiology of Hepatitis A i n  
Al Ain : with em phasis o n  age-related prevalence rate". 
who have signed 
below the volunteer himselflherself or the parent/guardian of the child 
____________________ Agree to participate in 
the above mentioned study by donation of 3 ml of blood after one of the 
research team fully explained to me the nature of the study and its importance 
to the community and that the extra amount of blood I am donating impose no 
health hazard upon me or the child whose name appears above. I hereby also 
declare that I know my right to withdraw from the study any time I so wish. 
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�� Of ABU DHABI 
l�WAM HOSPITAL 
�. 0, BOX : 1 5258 - AL AIN 
Voiled Arab Emirates 
Z l  J3ntlary 2004 
Associate Prof Yousef Abu-Zeid 
Pri nciple Investigator 
Dept of Biology, Col lege of Science 
UAEV, r.O.Box 1 755 1 Al Ain 
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Subj ec1 :  Proposal 58 - "Epidemiology of Hepatitis A in A I  A in: with Emphasis 
all Age-related Prevalence Rate " 
Dear Prof. Abu-Zeid, 
Thank you for submltting lhe consent form in Arabic and the exact Arabic translation of 
the English version of the information sheet. 
I co;1fiml that this now been accepted by the Coounittee and thus the study is now 
approved fully, 
We should reqillre from you in 1 2  months time an interim report on the progress of your 
Study and the Committee would like to have site of copies of their tracks and publications 
that arise as a rcsuJ t o f your rcsearch, 




�"'o fessor Mich ael Ellis 
Chairman,  Research Review Committee 
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